Use these links to rapidly review the document
TABLE OF CONTENTS
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the quarter ended September 30, 2014
COMMISSION FILE NO. 1 - 10421
LUXOTTICA GROUP S.p.A.
PIAZZALE L. CADORNA 3, MILAN, 20123 ITALY
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F ý Form 40-F o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): o
Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes o No ý
If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-
Board of Directors
In office until the approval of the financial statements as of and for the year ending December 31, 2014.
Chairman and CEO | Leonardo Del Vecchio | |
Deputy Chairman | Luigi Francavilla | |
Directors |
Mario Cattaneo* |
|
Claudio Costamagna* | ||
Claudio Del Vecchio | ||
Elisabetta Magistretti* | ||
Marco Mangiagalli* | ||
Anna Puccio* | ||
Marco Reboa* (Lead Independent Director) |
Human Resources Committee | Claudio Costamagna (Chairman) | |
Marco Mangiagalli | ||
Anna Puccio | ||
Control and Risk Committee |
Mario Cattaneo (Chairman) |
|
Elisabetta Magistretti | ||
Marco Mangiagalli | ||
Marco Reboa |
Board of Statutory Auditors
In office until the approval of the financial statements as of and for the year ending December 31, 2014
Regular Auditors |
Francesco Vella (Chairman) | |
|
Alberto Giussani | |
|
Barbara Tadolini | |
Alternate Auditors |
Giorgio Silva |
|
|
Fabrizio Riccardo di Giusto | |
Officer Responsible for Preparing the Company's Financial Reports |
Enrico Cavatorta |
|
Auditing Firm |
PricewaterhouseCoopers SpA |
Until approval of the financial statements as of and for the year ending December 31, 2020.
Luxottica Group S.p.A.
Headquarters and registered office Piazzale L. Cadorna 3, 20123 Milan, Italy
Capital Stock € 28,844,101.08
authorized and issued
ITEM 1. MANAGEMENT REPORT ON THE INTERIM
FINANCIAL RESULTS AS OF SEPTEMBER 30, 2014
(UNAUDITED)
The following should be read in connection with the disclosure contained in the consolidated financial statements as of December 31, 2013, which includes a discussion of risks and uncertainties that can influence the Group's operational results or financial position.
1. OPERATING PERFORMANCE FOR THE THREE-MONTH AND NINE-MONTH PERIODS ENDED SEPTEMBER 30, 2014
The Group's growth in the first nine months of 2014 was significantly affected by the weakening of certain currencies in which it operates. At constant exchange rates(1), the Group delivered solid growth in the main markets in which it conducts business.
In the first nine months of 2014 net sales increased to Euro 5,785.3 million from Euro 5,666.7 million (+2.1 percent at current exchange rates and +5.5 percent at constant exchange rates(1)). In the first nine months of 2014, adjusted net sales(2) increased to Euro 5,808.0 million from Euro 5,666.7 million in the same period of last year. Starting in the third quarter of 2014, adjusted net sales include a change in the presentation of a component of EyeMed net sales that was previously included in net sales on a gross basis and is currently included on a net basis due to a change in the terms of an insurance underwriting agreement resulting in a reduction of net sales and cost of goods sold of Euro 22.7 million (the "2014 EyeMed Adjustment").
In the third quarter of 2014 net sales increased to Euro 1,883.0 million from Euro 1,785.0 million in the same period of 2013 (+5.5 percent at current exchange rates and +5.3 percent at constant exchange rates(1)).
In the third quarter of 2014 adjusted net sales,(2) including the Euro 22.7 million EyeMed Adjustment, increased by 6.8 percent (+6.7 percent at constant exchange rates(1)) to Euro 1,905.7 million from Euro 1,785.0 million in the same period of last year.
Earnings before Interest, Taxes, Depreciation and Amortization ("EBITDA")(3) in the first nine months of 2014 increased by 5.3 percent to Euro 1,227.6 million from Euro 1,165.9 million in the same period of 2013. Adjusted EBITDA(3) in the first nine months of 2014 increased by 5.8 percent to Euro 1,242.6 million as compared to Euro 1,174.9 million in the same period of 2013.
EBITDA(3) in the third quarter of 2014 increased by 9.4 percent to Euro 379.5 million from Euro 346.9 million in the same period of 2013. Adjusted EBITDA(3) in the third quarter of 2014 increased by 13.7 percent to Euro 394.5 million from Euro 346.9 million in the same period of 2013.
1
Operating income for the first nine months of 2014 increased by 6.3 percent to Euro 947.5 million from Euro 891.6 million during the same period of the previous year. The Group's operating margin(4) in the first nine months of 2014 was 16.4 percent as compared to 15.7 percent in the same period of last year. Adjusted operating income(5) for the first nine months of 2014 increased by 6.9 percent to Euro 962.5 million as compared to Euro 900.6 million in the same period of last year. The Group's Adjusted operating margin(4) in the first nine months of 2014 was 16.6 percent as compared to 15.9 percent in the same period of last year.
Operating income for the third quarter of 2014 increased by 10.2 percent to Euro 281.2 million from Euro 255.1 million during the same period of the previous year. The Group's operating margin(4) in the third quarter of 2014 was 14.9 percent as compared to 14.3 percent in the same period of last year.
Adjusted operating income(5) for the third quarter of 2014 increased by 16.1 percent to Euro 296.2 million from operating income of Euro 255.1 million in the same period of the previous year.
The Group's adjusted operating margin(4) in the third quarter of 2014 was 15.5 percent as compared to operating margin of 14.3 percent in the same period of last year.
In the first nine months of 2014, net income attributable to Luxottica Stockholders increased by 7.0 percent to Euro 555.0 million from Euro 518.8 million in the same period of 2013. In the first nine months of 2014 adjusted net income attributable to Luxottica Stockholders(6) increased by 7.9 percent to Euro 565.9 compared to Euro 524.7 million in the same period of 2013. Earnings per share ("EPS") was Euro 1.17 and EPS expressed in USD was 1.58 (at an average rate of Euro/USD of 1.3549).
In the third quarter of 2014, net income attributable to Luxottica Stockholders increased by 10.1 percent to Euro 162.4 million from Euro 147.6 million in the same period of 2013. In the third quarter of 2014, adjusted net income attributable to Luxottica Stockholders(6) increased by 17.5 percent to Euro 173.3 million from net income attributable to Luxottica Stockholders of Euro 147.6 million in the same period of 2013. EPS was Euro 0.34 and EPS expressed in USD was 0.45 (at an average rate of Euro/USD of 1.3256).
By carefully controlling working capital, the Group generated positive free cash flow(7) in the first nine months of 2014 equal to Euro 696.9 million, of which Euro 315.8 million was generated in the third quarter of 2014. After paying dividends of Euro 308.3 million net debt(8) as of September 30, 2014 was Euro 1,118.7 million (Euro 1,461 million at the end of 2013), with a ratio of net debt to adjusted EBITDA(8) of 0.7x (1.0x as of December 31, 2013).
2. SIGNIFICANT EVENTS DURING THE NINE MONTHS ENDED SEPTEMBER 30, 2014
January
Luxottica Group S.p.A. announced that Standard & Poor's raised its long-term credit rating to A- from BBB+. The outlook is stable. Standard & Poor's disclosed that Luxottica improved its credit metrics since its long-term rating outlook was increased to positive on March 27, 2013.
On January 31, 2014, the Group closed the acquisition of glasses.com from WellPoint Inc. The transaction was previously announced on January 7, 2014.
March
On March 24, 2014, the Group and Google Inc. announced they are joining forces to design, develop and distribute a new breed of eyewear for Glass products. Luxottica's two major proprietary brands, Ray-Ban and Oakley, will be a part of the collaboration for Glass. In particular, the two companies will establish a team of experts devoted to working on the design, development, tooling and engineering of Glass products that straddle the line between high-fashion, lifestyle and innovative technology.
2
April
On April 15, 2014, Luxottica Group and Michael Kors Holdings Limited announced they signed a new and exclusive eyewear license agreement for the Michael Kors Collection and MICHAEL Michael Kors eyewear with a term of 10 years. The first collection produced with Luxottica will launch in January 2015. The brand's two luxury eyewear collections will be carried around the world in Michael Kors stores, department stores, select travel retail locations, independent optical locations and Luxottica's retail stores.
At the Stockholders' Meeting on April 29, 2014, Group's stockholders approved the Statutory Financial Statements as of December 31, 2013, as proposed by the Board of Directors and the distribution of a cash dividend of Euro 0.65 per ordinary share. The aggregate dividend amount of Euro 308.3 million was fully paid in May 2014.
September
On September 1, 2014, following a period of debate with Chairman Leonardo Del Vecchio over the Group's future strategy and direction, Andrea Guerra left as Group CEO ("Former Group CEO").
After the resignation of the Former Group CEO, Luxottica Group announced the introduction of a new management structure based on a co-CEO model; one focused on Markets and the other dedicated to Corporate Functions, in order to ensure a stronger management of the Group.
Enrico Cavatorta, General Manager and CFO of the Group, on September 1, 2014 was appointed CEO of Corporate Functions and was also named as Interim CEO of Markets, pending the appointment of a permanent executive to this position. Mr. Cavatorta resigned this role in October 2014 but retained his position as the Manager charged with preparing the Group's financial reports until he departed Luxottica on October 31, 2014.
3. FINANCIAL RESULTS
We are a global leader in the design, manufacture and distribution of fashion, luxury and sport eyewear, with net sales reaching Euro 7.3 billion in 2013, over 73,400 employees and a strong global presence. We operate in two industry segments: (i) manufacturing and wholesale distribution; and (ii) retail distribution. See Note 5 to the Condensed Consolidated Financial Report as of September 30, 2014 (unaudited) for additional disclosures about our operating segments. Through our manufacturing and wholesale distribution segment, we are engaged in the design, manufacture, wholesale distribution and marketing of proprietary and designer lines of mid- to premium-priced prescription frames and sunglasses. We operate our retail distribution segment principally through our retail brands, which include, among others, LensCrafters, Sunglass Hut, OPSM, Laubman & Pank, Oakley "O" Stores and Vaults, David Clulow, GMO and our Licensed Brands (Sears Optical and Target Optical).
As a result of our numerous acquisitions and the subsequent expansion of our business activities in the United States through various acquisitions, our results of operations, which are reported in Euro, are susceptible to currency rate fluctuations between the Euro and the U.S. dollar. The Euro/U.S. dollar exchange rate has fluctuated to an average exchange rate of Euro 1.00 = U.S. $1.3549 in the first nine months of 2014 from Euro 1.00 = U.S. $1.3167 in the same period of 2013. Since the acquisition of OPSM, our results of operations have also been rendered susceptible to currency fluctuations between the Euro and the Australian dollar. Additionally, we incur part of our manufacturing costs in Chinese Yuan; therefore, the fluctuation of the Chinese Yuan relative to other currencies in which we receive revenues could impact the demand of our products or our consolidated profitability. Although we engage in certain foreign currency hedging activities to mitigate the impact of these fluctuations, they have impacted our reported revenues and expenses during the periods discussed herein. This discussion should be read in conjunction with the risk factor discussion in Section 8 of the Management Report included with the 2013 Consolidated Financial Statements.
3
RESULTS OF OPERATIONS FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2014 AND 2013 (UNAUDITED)
In accordance with IFRS
|
Nine months ended September 30, |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
(Amounts in thousands of Euro) |
2014 |
% of net sales |
2013 |
% of net sales |
|||||||||
Net sales |
5,785,282 | 100.0 | % | 5,666,720 | 100.0 | % | |||||||
Cost of sales |
1,955,366 | 33.8 | % | 1,930,969 | 34.1 | % | |||||||
| | | | | | | | | | | | | |
Gross profit |
3,829,916 | 66.2 | % | 3,735,751 | 65.9 | % | |||||||
| | | | | | | | | | | | | |
Selling |
1,710,560 | 29.6 | % | 1,697,999 | 30.0 | % | |||||||
Royalties |
112,352 | 1.9 | % | 109,105 | 1.9 | % | |||||||
Advertising |
381,202 | 6.6 | % | 364,919 | 6.4 | % | |||||||
General and administrative |
678,260 | 11.7 | % | 672,132 | 11.9 | % | |||||||
Total operating expenses |
2,882,375 | 49.8 | % | 2,844,155 | 50.2 | % | |||||||
| | | | | | | | | | | | | |
Income from operations |
947,541 | 16.4 | % | 891,596 | 15.7 | % | |||||||
| | | | | | | | | | | | | |
Other income/(expense) |
|||||||||||||
Interest income |
8,994 | 0.2 | % | 6,652 | 0.1 | % | |||||||
Interest expense |
(80,764 | ) | (1.4 | )% | (76,872 | ) | (1.4 | )% | |||||
Othernet |
(367 | ) | (0.0 | )% | (4,911 | ) | (0.1 | )% | |||||
| | | | | | | | | | | | | |
Income before provision for income taxes |
875,405 | 15.1 | % | 816,466 | 14.4 | % | |||||||
| | | | | | | | | | | | | |
Provision for income taxes |
(316,373 | ) | (5.5 | )% | (293,919 | ) | (5.2 | )% | |||||
| | | | | | | | | | | | | |
Net income |
559,031 | 9.7 | % | 522,547 | 9.2 | % | |||||||
| | | | | | | | | | | | | |
Attributable to |
|||||||||||||
Luxottica Group stockholders |
554,982 | 9.6 | % | 518,755 | 9.2 | % | |||||||
non-controlling interests |
4,049 | 0.1 | % | 3,792 | 0.1 | % | |||||||
| | | | | | | | | | | | | |
NET INCOME |
559,031 | 9.7 | % | 522,547 | 9.2 | % | |||||||
In order to provide the reader of this report with a meaningful comparison of the information included in the condensed consolidated financial statements as of September 30, 2014, certain prior year comparative information has been revised to conform to the current year presentation. The revision relates to the reclassification of the warehouse and shipping expenses of certain subsidiaries of the Company from general and administrative expenses and selling expenses to cost of sales. The Company has determined that the revision, totaling Euro 44.1 million, is immaterial to the previously reported financial statements.
In order to provide the reader of this report with a meaningful comparison of the information as of and for the period ended September 30, 2014, certain items are adjusted as follows: (i) in the first nine months of 2014, the Group incurred non-recurring expenses of Euro 15.0 million (Euro 10.9 million net of the tax effect) related to the termination of the Former Group CEO and (ii) starting in the third quarter of 2014, adjusted net sales include the 2014 EyeMed adjustment as defined above.
4
In the first nine months of 2013, the Group incurred non-recurring expenses of Euro 9.0 million (Euro 5.9 million net of the tax effect), related to the reorganization of Alain Mikli International.
|
2014 |
% of net sales |
2013 |
% of net sales |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Adjusted Measures(9) |
|||||||||||||
Adjusted net sales |
5,807,960 | | | | |||||||||
Adjusted cost of sales |
1,978,044 | 34.1 | % | | | ||||||||
Adjusted income from operations |
962,541 | 16.6 | % | 900,596 | 15.9 | % | |||||||
Adjusted EBITDA |
1,242,564 | 21.4 | % | 1,174,915 | 20.7 | % | |||||||
Adjusted net income attributable to Luxottica Group stockholders |
565,858 | 9.7 | % | 524,659 | 9.3 | % | |||||||
Net Sales. Net sales increased by Euro 118.6 million, or 2.1 percent, to Euro 5,785.3 million in the first nine months of 2014 from Euro 5,666.7 million in the same period of 2013. Net sales in the manufacturing and wholesale distribution segment in the first nine months of 2014 as compared to the same period in 2013 increased by Euro 142.4 million, whereas net sales in the retail distribution segment decreased by Euro 23.8 million for the same period. Adjusted net sales(10) in the first nine months of 2014, which include the 2014 EyeMed Adjustment, were Euro 5,808.0 million.
Please find the reconciliation between adjusted net sales(10) and net sales in the following table:
(Amounts in millions of Euro) |
2014 |
2013 |
|||||
---|---|---|---|---|---|---|---|
Net sales |
5,785.3 | 5,666.7 | |||||
> EyeMed net sales presented on a net basis starting from the third quarter of 2014 |
22.7 | | |||||
| | | | | | | |
Adjusted net sales |
5,808.0 | 5,666.7 | |||||
Net sales for the retail distribution segment decreased by Euro 23.8 million, or 0.7 percent, to Euro 3,295.8 million in the first nine months of 2014 from Euro 3,319.6 million in the same period in 2013. Although there was an overall decrease, the retail segment recorded a 3.7 percent improvement in comparable store sales(11). In particular, comparable store sales for the North American retail operations increased in the first nine months of 2014 as compared to the same period of last year (+2.7 percent). During the same periods the Australian/New Zealand retail operations increased 3.1 percent. The effects from currency fluctuations between the Euro (which is our reporting currency) and other currencies in which we conduct business, in particular the weakening of the U.S. dollar and Australian dollar compared to the Euro, decreased net sales in the retail distribution segment by Euro 121.7 million during the period.
Adjusted net sales(10) of the retail division in the first nine months of 2014, which include the 2014 EyeMed Adjustment, were Euro 3,318.4 million.
5
Please find the reconciliation between adjusted net sales(10) of the retail division and net sales of the retail division in the following table:
(Amounts in millions of Euro) |
2014 |
2013 |
|||||
---|---|---|---|---|---|---|---|
Net sales |
3,295.8 | 3,319.6 | |||||
> EyeMed net sales presented on a net basis starting from the third quarter of 2014 |
22.7 | | |||||
| | | | | | | |
Adjusted net sales |
3,318.4 | 3,319.6 | |||||
Net sales to third parties in the manufacturing and wholesale distribution segment increased by Euro 142.4 million, or 6.1 percent, to Euro 2,489.5 million in the first nine months of 2014 from Euro 2,347.1 million in the same period in 2013. This growth was mainly attributable to increased sales of most of our proprietary brands, in particular Ray-Ban and of certain licensed brands such as Armani. Almost all of the primary geographic markets in which the Group operates recorded an increase in net sales. These positive effects were partially offset by negative currency fluctuations, in particular the weakening of the U.S. Dollar and the Brazilian Real, which decreased net sales to third parties in the manufacturing and wholesale distribution segment by Euro 74.1 million.
In the first nine months of 2014, net sales in the retail distribution segment accounted for approximately 57.0 percent of total net sales, as compared to approximately 58.6 percent of total net sales for the same period in 2013.
In the first nine months of 2014, net sales in our retail distribution segment in the United States and Canada comprised 77.5 percent of our total net sales in this segment as compared to 78.4 percent of our total net sales in the same period of 2013. In U.S. dollars, retail net sales in the United States and Canada slightly increased by 1.0 percent to USD 3,458.5 million in the first nine months of 2014 from USD 3,425.7 million for the same period in 2013. During the first nine months of 2014, net sales in the retail distribution segment in the rest of the world (excluding the United States and Canada) comprised 22.5 percent of our total net sales in the retail distribution segment and increased by 3.5 percent to Euro 743.1 million in the first nine months of 2014 from Euro 717.9 million, or 21.6 percent of our total net sales in the retail distribution segment for the same period in 2013.
In the first nine months of 2014, net sales to third parties in our manufacturing and wholesale distribution segment in Europe increased by Euro 39.0 million, or 3.9 percent, to Euro 1,052.2 million, comprising 42.3 percent of our total net sales in this segment, compared to Euro 1,013.2 million, or 43.2 percent of total net sales in the segment, for the same period in 2013. Net sales to third parties in our manufacturing and wholesale distribution segment in the United States and Canada were USD 878.8 million and comprised 26.1 percent of our total net sales in this segment for the first nine months of 2014, compared to USD 810.1 million, or 26.2 percent of total net sales in the segment, for the same period of 2013. The increase in net sales in the United States and Canada was primarily due to a general increase in consumer demand. In the first nine months of 2014, net sales to third parties in our manufacturing and wholesale distribution segment in the rest of the world increased by Euro 70.0 million or 9.7 percent to Euro 788.7 million, comprising 31.7 percent of our total net sales in this segment, compared to Euro 718.7 million, or 30.6 percent of our net sales in this segment, in the same period of 2013.
Cost of Sales. Cost of sales increased by Euro 24.4 million, or 2.5 percent, to Euro 1,955.4 million in the first nine months of 2014 from Euro 1,931.0 million in the same period of 2013. As a percentage of net sales, cost of sales decreased to 33.8 percent in the first nine months of 2014 as compared to 34.1 percent in the same period of 2013. In the first nine months of 2014, the average number of frames produced daily in our facilities was approximately 295,000 as compared to approximately 305,700 in the same period of 2013.
6
Adjusted cost of sales(12) in the first nine months of 2014, which include cost of sales related to EyeMed equal to Euro 22.7 million, was Euro 1,978.0 million.
Please find the reconciliation between adjusted cost of sales(12) and cost of sales in the following table:
(Amounts in millions of Euro) |
2014 |
2013 |
|||||
---|---|---|---|---|---|---|---|
Cost of sales |
1,955.4 | 1,931.0 | |||||
> EyeMed cost of sales presented on a net basis starting from the third quarter of 2014 |
22.7 | | |||||
| | | | | | | |
Adjusted cost of sales |
1,978.0 | 1,931.0 | |||||
Gross Profit. Our gross profit increased by Euro 94.2 million, or 2.5 percent, to Euro 3,829.9 million in the first nine months of 2014 from Euro 3,735.8 million for the same period of 2013. As a percentage of net sales, gross profit increased to 66.2 percent in the first nine months of 2014 as compared to 65.9 percent for the same period of 2013, due to the factors noted above.
Operating Expenses. Total operating expenses increased by Euro 38.2 million, or 1.3 percent, to Euro 2,882.4 million in the first nine months of 2014 from Euro 2,844.2 million in the same period of 2013. As a percentage of net sales, operating expenses decreased to 49.8 percent in the first nine months of 2014, from 50.2 percent in the same period of 2013.
Adjusted operating expenses(13), excluding in the first nine months of 2014 non-recurring expenses of Euro 15.0 million related to the termination of the Former Group CEO and in the first nine months of 2013 non-recurring expenses related to the reorganization of Alain Mikli International amounting to approximately Euro 9.0 million, were Euro 2,867.4 million and 2,835.2 million, respectively. As a percentage of net sales, adjusted operating expenses(13) were at 49.4 percent and 50.0 percent in the first nine months of 2014 and 2013, respectively.
Please find the reconciliation between adjusted operating expenses(13) and operating expenses in the following table:
(Amounts in millions of Euro) |
2014 |
2013 |
|||||
---|---|---|---|---|---|---|---|
Operating expenses |
2,882.4 | 2,844.2 | |||||
> Adjustment for termination of the Former Group CEO |
(15.0 | ) | | ||||
> Adjustment for Alain Mikli reorganization |
| (9.0 | ) | ||||
| | | | | | | |
Adjusted operating expenses |
2,867.4 | 2,835.2 | |||||
Selling and advertising expenses (including royalty expenses) increased by Euro 32.1 million, or 1.5 percent, to Euro 2,204.1 million in the first nine months of 2014 from Euro 2,172.0 million in the same period of 2013. Selling expenses increased by Euro 12.6 million, or 0.7 percent. Advertising expenses increased by Euro 16.3 million, or 4.5 percent. Royalties increased by Euro 3.2 million, or 3.0 percent. As a percentage of net sales, selling and advertising expenses (including royalty expenses) were 38.1 percent in the first nine months of 2014 and 38.3 percent in the same period of 2013.
General and administrative expenses, including intangible asset amortization increased by Euro 6.1 million, or 0.9 percent, to Euro 678.3 million in the first nine months of 2014 as compared to Euro 672.1 million in the same period of 2013. As a percentage of net sales, general and administrative
7
expenses were 11.7 percent in the first nine months of 2014 as compared to 11.9 percent in the same period of 2013.
Adjusted general and administrative expenses(14), including intangible asset amortization and excluding in the first nine months of 2014, non-recurring expenses related to termination of the Former Group CEO of 15.0 million and in the first nine months of 2013, non-recurring expenses related to the reorganization of Alain Mikli International amounting to Euro 9.0 million, totaled Euro 663.3 million in 2014 and 663.1 million in 2013 . As a percentage of net sales, adjusted general and administrative expenses(14) were 11.4 percent in the first nine months of 2014 and 11.7 percent in 2013.
Please find the reconciliation between adjusted general and administrative expenses(14) and general and administrative expenses in the following table:
(Amounts in millions of Euro) |
2014 |
2013 |
|||||
---|---|---|---|---|---|---|---|
General and administrative expense |
678.3 | 672.1 | |||||
> Adjustment for termination of the Former Group CEO |
(15.0 | ) | | ||||
> Adjustment for Alain Mikli reorganization |
| (9.0 | ) | ||||
| | | | | | | |
Adjusted general and administrative expense |
663.3 | 663.1 | |||||
Income from Operations. For the reasons described above, income from operations increased by Euro 55.9 million, or 6.3 percent, to Euro 947.5 million in the first nine months of 2014 from Euro 891.6 million in the same period of 2013. As a percentage of net sales, income from operations increased to 16.4 percent in the first nine months of 2014 as compared to 15.7 percent in the same period of 2013.
Adjusted income from operations(15), excluding, in the first nine months of 2013 and 2014 , the above mentioned non-recurring expenses related to termination of the Former Group CEO for Euro 15.0 million and the reorganization of Alain Mikli International for Euro 9.0 million, amounted to Euro 962.6 million in 2014 and 900.6 million in 2013. As a percentage of net sales, adjusted income from operations(15) was 16.6 percent in the first nine months of 2014 and 15.9 percent in the first nine months of 2013.
Please find the reconciliation between adjusted income from operations(15) and income from operations in the following table:
(Amounts in millions of Euro) |
2014 |
2013 |
|||||
---|---|---|---|---|---|---|---|
Income from operations |
947.5 | 891.6 | |||||
> Adjustment for termination of the Former Group CEO |
15.0 | | |||||
> Adjustment for Alain Mikli reorganization |
| 9.0 | |||||
| | | | | | | |
Adjusted income from operations |
962.5 | 900.6 | |||||
Other Income (Expense)Net. Other income (expense)net was Euro (72.1) million in the first nine months of 2014 as compared to Euro (75.1) million in the same period of 2013. Net interest expense was Euro 71.8 million in the first nine months of 2014 as compared to Euro 70.2 million in the same period of 2013.
Net Income. Income before taxes increased by Euro 58.9 million, or 7.2 percent, to Euro 875.4 million in the first nine months of 2014 from Euro 816.5 million in the same period of 2013, for the reasons
8
described above. As a percentage of net sales, income before taxes was 15.1 percent in the first nine months of 2014 as compared to 14.4 percent in the same period of 2013.
Adjusted income before taxes(16) amounted to Euro 890.4 in the first nine months of 2014 and Euro 825.5 million in the same period of 2013. As a percentage of net sales, adjusted income before taxes(16) was 15.3 percent in the first nine months of 2014 and 14.6 percent in the same period of 2013. Please find the reconciliation between adjusted income before taxes(16) and income before taxes in the following table:
(Amounts in millions of Euro) |
2014 |
2013 |
|||||
---|---|---|---|---|---|---|---|
Income before taxes |
875.4 | 816.5 | |||||
> Adjustment for termination of the Former Group CEO |
15.0 | | |||||
> Adjustment for Alain Mikli reorganization |
| 9.0 | |||||
| | | | | | | |
Adjusted income before taxes |
890.4 | 825.5 | |||||
Net income attributable to non-controlling interests in the first nine months of 2014, increased to Euro 4.0 million from Euro 3.8 million in the same period of 2013. The expected tax rate was 36.1 and 36.0 percent in the first nine months of 2014 and 2013.
Net income attributable to Luxottica Group stockholders increased by Euro 36.2 million, or 7.0 percent, to Euro 550.0 million in the first nine months of 2014 from Euro 518.8 million in the same period of 2013. Net income attributable to Luxottica Group stockholders as a percentage of net sales was 9.6 percent in the first nine months of 2014 and 9.2 percent in the same period of 2013.
Adjusted net income attributable to Luxottica Group stockholders(17) increased to Euro 565.9 from Euro 524.7 million in the nine month period ended September 30, 2014 and 2013. As a percentage of net sales, adjusted net income attributable to Luxottica Group stockholders(17) was at 9.7 percent and 9.3 percent in the first nine months of 2014 and 2013 respectively.
Please find the reconciliation between adjusted net income attributable to Luxottica Group stockholders(17) in the following table:
(Amounts in millions of Euro) |
2014 |
2013 |
|||||
---|---|---|---|---|---|---|---|
Net Income attributable to Luxottica Group stockholders |
550.0 | 518.8 | |||||
> Adjustment for termination of the Former Group CEO |
10.9 | | |||||
> Adjustment for Alain Mikli reorganization |
| 5.9 | |||||
| | | | | | | |
Adjusted Net Income attributable to Luxottica Group stockholders |
565.9 | 524.7 | |||||
Basic and diluted earnings per share were Euro 1.17 and 1.16 in the first nine months of 2014 respectively. In the same period of 2013, basic and diluted earnings per share were Euro 1.10 and 1.09 respectively.
Adjusted basic earnings per share(18) was Euro 1.19 and 1.11 in the first nine months of 2014 and 2013 respectively. Adjusted diluted earnings per share(18) was Euro 1.18 and Euro 1.10 in the first nine months of 2014 and 2013 respectively.
9
RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2014 AND 2013 (UNAUDITED)
In accordance with IFRS
|
Three months ended September 30, |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
(Amounts in thousands of Euro) |
2014 |
% of net sales |
2013 |
% of net sales |
|||||||||
Net sales |
1,882,969 | 100.0 | % | 1,784,992 | 100.0 | % | |||||||
Cost of sales |
605,552 | 32.2 | % | 607,091 | 34.0 | % | |||||||
| | | | | | | | | | | | | |
Gross profit |
1,277,417 | 67.8 | % | 1,177,901 | 66.0 | % | |||||||
| | | | | | | | | | | | | |
Selling |
590,457 | 31.4 | % | 553,480 | 31.0 | % | |||||||
Royalties |
36,722 | 2.0 | % | 32,772 | 1.8 | % | |||||||
Advertising |
132,408 | 7.0 | % | 119,601 | 6.7 | % | |||||||
General and administrative |
236,633 | 12.6 | % | 216,944 | 12.2 | % | |||||||
| | | | | | | | | | | | | |
Total operating expenses |
996,221 | 52.9 | % | 922,797 | 51.7 | % | |||||||
| | | | | | | | | | | | | |
Income from operations |
281,195 | 14.9 | % | 255,105 | 14.3 | % | |||||||
| | | | | | | | | | | | | |
Other income/(expense) |
|||||||||||||
Interest income |
3,154 | 0.2 | % | 1,615 | 0.1 | % | |||||||
Interest expense |
(27,445 | ) | (1.5 | )% | (24,033 | ) | (1.3 | )% | |||||
Othernet |
(14 | ) | (0.0 | )% | (803 | ) | (0.0 | )% | |||||
| | | | | | | | | | | | | |
Income before provision for income taxes |
256,891 | 13.6 | % | 231,884 | 13.0 | % | |||||||
| | | | | | | | | | | | | |
Provision for income taxes |
(93,706 | ) | (5.0 | )% | (83,420 | ) | (4.7 | )% | |||||
| | | | | | | | | | | | | |
Net income |
163,184 | 8.7 | % | 148,464 | 8.3 | % | |||||||
| | | | | | | | | | | | | |
Attributable to |
|||||||||||||
Luxottica Group stockholders |
162,441 | 8.6 | % | 147,557 | 8.3 | % | |||||||
non-controlling interests |
743 | 0.0 | % | 907 | 0.1 | % | |||||||
| | | | | | | | | | | | | |
NET INCOME |
163,184 | 8.7 | % | 148,464 | 8.3 | % | |||||||
| | | | | | | | | | | | | |
In order to provide the reader of this report with a meaningful comparison of the information included in the condensed consolidated financial statements as of September 30, 2014, certain prior year comparative information has been revised to conform to the current year presentation. The revision relates to the reclassification of the warehouse and shipping expenses of certain subsidiaries of the Company from general and administrative expenses and selling expenses to cost of sales. The Company has determined that the revision, totaling Euro 13.6 million, is immaterial to the previously reported financial statements.
In order to provide the reader of this report with a meaningful comparison of the information as of and for the period ended September 30, 2014, certain items are adjusted as follows: (i) in the third quarter of 2014, the Group incurred non-recurring expenses for Euro 15.0 million (Euro 10.9 million net of the tax
10
effect) related to the termination of the Former Group CEO and (ii) starting in the third quarter of 2014, adjusted net sales include the 2014 EyeMed adjustment as defined above.
|
Three months ended September 30, 2014 |
% of net sales |
|||||
---|---|---|---|---|---|---|---|
Adjusted Measures(19) |
|||||||
Adjusted net sales |
1,905,647 | | |||||
Adjusted cost of sales |
628,230 | 33.0 | % | ||||
Adjusted income from operations |
296,196 | 15.5 | % | ||||
Adjusted EBITDA |
394,538 | 20.7 | % | ||||
Adjusted net income attributable to Luxottica Group stockholders |
173,317 | 9.1 | % | ||||
Net Sales. Net sales increased by Euro 98.0 million, or 5.5 percent, to Euro 1,883.0 million in the three months ended September 30, 2014 from Euro 1,785.0 million in the same period of 2013. Net Sales growth was due to the increase in the manufacturing and wholesale distribution segment in the three months ended September 30, 2014 of Euro 64.0 million and increase in the retail distribution segment of Euro 34.0 million.
Adjusted net sales(20) in the three months ended September 30, 2014, which include the 2014 EyeMed Adjustment, were Euro 1,905.7 million.
Please find the reconciliation between adjusted net sales(20) and net sales in the following table:
(Amounts in millions of Euro) |
Three months ended September 30, 2014 |
Three months ended September 30, 2013 |
|||||
---|---|---|---|---|---|---|---|
Net sales |
1,883.0 | 1,785.0 | |||||
> EyeMed net sales presented on a net basis starting from the third quarter of 2014 |
22.7 | | |||||
| | | | | | | |
Adjusted net sales |
1,905.7 | 1,785.0 | |||||
Net sales for the retail distribution segment increased by Euro 34.0 million, or 3.1 percent, to Euro 1,132.8 million in the three months ended September 30, 2014 from Euro 1,098.9 million in the same period in 2013. The retail segment recorded a 4.4 percent improvement in comparable store sales(21). In particular, we saw a 4.3 percent increase in comparable store sales(21) for the North American retail operations, and a 1.3 percent increase for the Australian/New Zealand retail operations. The effects from currency fluctuations between the Euro (which is our reporting currency) and other currencies in which we conduct business, in particular the strengthening of the U.S. dollar and Australian dollar compared to the Euro, increased net sales in the retail distribution segment by Euro 2.4 million during the period.
Adjusted net sales(20) of the retail division in the third quarter of 2014, which include the 2014 EyeMed Adjustment, were Euro 1,155.5 million.
11
Please find the reconciliation between adjusted net sales(20) of the retail division and net sales of the retail division in the following table:
(Amounts in millions of Euro) |
Three months ended September 30, 2014 |
Three months ended September 30, 2013 |
|||||
---|---|---|---|---|---|---|---|
Net sales |
1,132.8 | 1,098.9 | |||||
> EyeMed net sales presented on a net basis starting from the third quarter of 2014 |
22.7 | | |||||
| | | | | | | |
Adjusted net sales |
1,155.5 | 1,098.9 | |||||
Net sales to third parties in the manufacturing and wholesale distribution segment increased by Euro 64.0 million, or 9.3 percent, to Euro 750.1 million in the three months ended September 30, 2014 from Euro 686.1 million in the same period in 2013. This growth was mainly attributable to increased sales of most of our proprietary brands, in particular Ray-Ban and Oakley and of some licensed brands such as Prada. Almost all of the primary geographic markets in which the Group operates recorded an increase in net sales. The impact of currency fluctuations, in particular the strengthening of the U.S. dollar and other currencies, is immaterial on the net sales to third parties in the manufacturing and wholesale distribution segment
In the three months ended September 30, 2014, net sales in the retail distribution segment accounted for approximately 60.2 percent of total net sales, as compared to approximately 61.6 percent of total net sales for the same period in 2013.
In the three months ended September 30, 2014, net sales in our retail distribution segment in the United States and Canada comprised 76.8 percent of our total net sales in this segment as compared to 78.2 percent of our total net sales in the same period of 2013. In U.S. dollars, retail net sales in the United States and Canada increased by 1.2 percent to USD 1,152.5 million in the three months ended September 30, 2014 from USD 1,138.9 million for the same period in 2013. During the three months ended September 30, 2014, net sales in the retail distribution segment in the rest of the world (excluding the United States and Canada) comprised 23.2 percent of our total net sales in the retail distribution segment and increased by 10.0 percent to Euro 263.0 million in the three months ended September 30, 2014 from Euro 239.1 million, or 21.8 percent of our total net sales in the retail distribution segment for the same period in 2013.
In the three months ended September 30, 2014, net sales to third parties in our manufacturing and wholesale distribution segment in Europe decreased by Euro 3.5 million to Euro 273.9 million, comprising 36.5 percent of our total net sales in this segment, compared to Euro 277.5 million of total net sales in the segment, for the same period in 2013. Net sales to third parties in our manufacturing and wholesale distribution segment in the United States and Canada were USD 281.5 million and comprised 28.4 percent of our total net sales in this segment for the three months ended September 30, 2014, compared to USD 254.5 million, or 28.0 percent of total net sales in the segment, for the same period of 2013. In the three months ended September 30, 2014, net sales to third parties in our manufacturing and wholesale distribution segment in the rest of the world increased by Euro 46.8 million, or 21.6 percent, in the three months ended September 30, 2014 as compared to the same period of 2013, to Euro 263.4 million, comprising 35.1 percent of our total net sales in this segment, compared to Euro 216.6 million, or 31.6 percent of our net sales in this segment, in the same period of 2013.
Cost of Sales. Cost of sales decreased by Euro 1.5 million, or 0.3 percent, to Euro 605.6 million in the three months ended September 30, 2014 from Euro 607.1 million in the same period of 2013. As a percentage of net sales, cost of sales decreased to 32.2 percent in the three months ended September 30, 2014 as compared to 34.0 percent in the same period of 2013. In the three months ended September 30,
12
2014, the average number of frames produced daily in our facilities decreased to approximately 299,000 as compared to approximately 306,800 in the same period of 2013.
Adjusted Cost of sales(22) which include the 2014 EyeMed Adjustment, was Euro 628.2 million.
Please find the reconciliation between adjusted cost of sales(22) and cost of sales in the following table:
(Amounts in millions of Euro) |
Three months ended September 30, 2014 |
Three months ended September 30, 2013 |
|||||
---|---|---|---|---|---|---|---|
Cost of sales |
605.6 | 607.1 | |||||
> EyeMed cost of sales presented on a net basis starting from the third quarter of 2014 |
22.7 | | |||||
| | | | | | | |
Adjusted Cost of sales |
628.2 | 607.1 | |||||
Gross Profit. Our gross profit increased by Euro 99.5 million, or 8.4 percent, to Euro 1,277.4 million in the three months ended September 30, 2014 from Euro 1,177.9 million for the same period of 2013. As a percentage of net sales, gross profit increased to 67.8 percent in the three months ended September 30, 2014 as compared to 66.0 percent for the same period of 2013, due to the factors noted above.
Operating Expenses. Total operating expenses increased by Euro 73.4 million, or 8.0 percent, to Euro 996.2 million in the three months ended September 30, 2014 from Euro 922.8 million in the same period of 2013. As a percentage of net sales, operating expenses increased to 52.9 percent in the three months ended September 30, 2014, from 51.7 percent in the same period of 2013.
Adjusted operating expenses(23) excluding in the third quarter of 2014 a non-recurring expense of Euro 15.0 million related to the termination of the Former Group CEO, were Euro 981.2 million. As a percentage of net sales, adjusted operating expenses(23) were at 51.5 percent.
Please find the reconciliation between adjusted operating expenses(23) and operating expenses in the following table:
(Amounts in millions of Euro) |
Three months ended September 30, 2014 |
Three months ended September 30, 2013 |
|||||
---|---|---|---|---|---|---|---|
Operating expenses |
996.2 | 922.8 | |||||
> Adjustment for termination of the Former Group CEO |
(15.0 | ) | | ||||
Adjusted operating expenses |
981.2 | 922.8 | |||||
Selling and advertising expenses (including royalty expenses) increased by Euro 53.7 million, or 7.6 percent, to Euro 759.6 million in the three months ended September 30, 2014 from Euro 705.9 million in the same period of 2013. Selling expenses increased by Euro 37.0 million, or 6.7 percent. Advertising expenses increased by Euro 12.8 million, or 10.7 percent. Royalties increased by Euro 4.0 million, or 12.1 percent. As a percentage of net sales, selling and advertising expenses were 40.3 percent in the three months ended September 30, 2014 and 39.5 percent in the same period of 2013.
General and administrative expenses, including intangible asset amortization increased by Euro 19.7 million, or 9.1 percent, to Euro 236.6 million in the three months ended September 30, 2014 as compared to Euro 216.9 million in the same period of 2013. As a percentage of net sales, general and administrative expenses were 12.6 percent in the three months ended September 30, 2014 as compared to
13
12.2 percent in the same period of 2013. The increase is mainly due to the non-recurring expense related to the termination of the Former Group CEO as explained below.
Adjusted general and administrative expenses(24), including intangible asset amortization and excluding, in the three months ended September 30, 2014, the non-recurring expenses related to termination of the Former Group CEO of 15.0 million, were 221.6 million. As a percentage of net sales, adjusted general and administrative expenses(24) were 11.6 percent in the third quarter of 2014
Please find the reconciliation between adjusted general and administrative expenses(24) and general and administrative expenses in the following table:
(Amounts in millions of Euro) |
Three months ended September 30, 2014 |
Three months ended September 30, 2013 |
|||||
---|---|---|---|---|---|---|---|
General and administrative expense |
236.6 | 216.9 | |||||
> Adjustment for termination of the Former Group CEO |
(15.0 | ) | | ||||
Adjusted general and administrative expense |
221.6 | 216.9 | |||||
Income from Operations. For the reasons described above, income from operations increased by Euro 26.1 million, or 10.2 percent, to Euro 281.2 million in the three months ended September 30, 2014 from Euro 255.1 million in the same period of 2013. As a percentage of net sales, income from operations increased to 14.9 percent in the three months ended September 30, 2014 from 14.3 percent in the same period of 2013.
Adjusted income from operations(25), excluding in the third quarter of 2014, the above mentioned non-recurring expenses related to termination of the Former Group CEO for Euro 15.0 million, amounted to Euro 296.2 million in 2014. As a percentage of net sales, adjusted income from operations(25) was 15.5 percent in the third quarter of 2014.
Please find the reconciliation between adjusted income from operations(25) and income from operations in the following table:
(Amounts in millions of Euro) |
Three months ended September 30, 2014 |
Three months ended September 30, 2013 |
|||||
---|---|---|---|---|---|---|---|
Income from operations |
281.2 | 255.1 | |||||
> Adjustment for termination of the Former Group CEO |
15.0 | | |||||
Adjusted Income from operations |
296.2 | 255.1 | |||||
Other Income (Expense)Net. Other income (expense)net was Euro (24.3) million in the three months ended September 30, 2014 as compared to Euro (23.2) million in the same period of 2013. Net interest expense was Euro 24.3 million in the three months ended September 30, 2014 as compared to Euro 22.4 million in the same period of 2013.
Net Income. Income before taxes increased by Euro 25.0 million, or 10.8 percent, to Euro 256.9 million in the three months ended September 30, 2014 from Euro 231.9 million in the same period of 2013, for the reasons described above. As a percentage of net sales, income before taxes increased to 13.6 percent in the three months ended September 30, 2014 from 13.0 percent in the same period of 2013.
14
Adjusted income before taxes(26) amounted to Euro 271.9 million in the third quarter of 2014. As a percentage of net sales, adjusted income before taxes(26) was 14.3 percent in the third quarter of 2014
Please find the reconciliation between adjusted income before taxes(26) and income before taxes in the following table:
(Amounts in millions of Euro) |
Three months ended September 30, 2014 |
Three months ended September 30, 2013 |
|||||
---|---|---|---|---|---|---|---|
Income before taxes |
256.9 | 231.9 | |||||
> Adjustment for termination of the Former Group CEO |
15.0 | | |||||
Adjusted income before taxes |
271.9 | 231.9 | |||||
Net income attributable to non-controlling interests in the three months ended September 30, 2014, increased to Euro 0.7 million from Euro 0.9 million in the three months ended September 30, 2013.
Net income attributable to Luxottica Group stockholders increased by Euro 14.9 million, or 10.1 percent, to Euro 162.4 million in the three months ended September 30, 2014 from Euro 147.6 million in the same period of 2013. Net income attributable to Luxottica Group stockholders as a percentage of net sales increased to 8.6 percent in the three months ended September 30, 2014 from 8.3 percent in the same period of 2013.
Adjusted net income attributable to Luxottica Group stockholders(27) excluding non-recurring expenses related to termination of the Former Group CEO was 173.3 million in the third quarter of 2014. As a percentage of net sales adjusted net income attributable to Luxottica Group stockholders(27) equaled 9.1 percent in the three-month period ended September 30, 2014.
Please find the reconciliation between Adjusted net income attributable to Luxottica Group stockholders(27) and Net income attributable to Luxottica Group stockholders in the following table:
(Amounts in millions of Euro) |
2014 |
2013 |
|||||
---|---|---|---|---|---|---|---|
Net Income attributable to Luxottica Group stockholders |
162.4 | 147.6 | |||||
> Adjustment for termination of the Former Group CEO |
10.9 | | |||||
Adjusted net Income attributable to Luxottica Group stockholders |
173.3 | 147.6 | |||||
Basic earnings per share and diluted earnings per share were Euro 0.34 in the three months ended September 30, 2014. Basic earnings per share and diluted earnings per share were Euro 0.31 in the three months ended September 30, 2013.
Adjusted basic and diluted earnings(28) per share were Euro 0.36 in the third quarter of 2014.
15
OUR CASH FLOWS
The following table sets forth for the periods indicated certain items included in our statements of consolidated cash flows included in Item 2 of this report.
(Amounts in thousands of Euro) |
As of September 30, 2014 |
As of September 30, 2013 |
|||||||
---|---|---|---|---|---|---|---|---|---|
|
|
(unaudited) |
|||||||
A) |
Cash and cash equivalents at the beginning of the period |
617,995 | 790,093 | ||||||
B) |
Cash provided by operating activities (net) |
935,910 | 679,885 | ||||||
C) |
Cash used in investing activities |
(311,227 | ) | (341,128 | ) | ||||
D) |
Cash provided by/(used in) financing activities |
11,069 | (564,186 | ) | |||||
E) |
Effect of exchange rate changes on cash and cash equivalents |
44,302 | (26,946 | ) | |||||
F) |
Net change in cash and cash equivalents |
680,054 | (252,375 | ) | |||||
| | | | | | | | | |
G) |
Cash and cash equivalents at the end of the period |
1,298,049 | 537,718 | ||||||
| | | | | | | | | |
| | | | | | | | | |
Operating activities. Cash provided by operating activities was Euro 935.9 million and Euro 679.9 million for the first nine months of 2014 and 2013, respectively.
Depreciation and amortization were Euro 280.0 million in the first nine months of 2014 as compared to Euro 274.3 million in the same period of 2013.
Cash used in accounts receivable was Euro (79.2) million in the first nine months of 2014, compared to Euro (80.4) million in the same period of 2013. This change was primarily due to the improved timing of accounts receivable collections in the first nine months of 2014 as compared to the same period of 2013. Cash generated in inventory was Euro 21.9 million in the first nine months of 2014 as compared to Euro 2.1 million in the same period of 2013. The change in inventory in the first nine months of 2014 was due to better inventory management within the Group. Cash generated/(used) in accounts payable was Euro 0.3 million in the first nine months of 2014 compared to Euro (64.7) million in the same period of 2013. The decrease in cash used for accounts payable in 2014 as compared to 2013 is due to better payment terms negotiated by the Group beginning in 2012. Cash used in other assets and liabilities, risk funds and employee benefits was Euro (37.5) million and Euro (69.6) million in the first nine months of 2014 and 2013, respectively. The cash used in the first nine months of 2013 was mainly due to the payments made for advances on royalties. Income taxes paid were Euro (183.8) million in the first nine months of 2014 as compared to Euro (238.5) million in the same period of 2013. The reduction is mainly due to the timing of income tax payments in the different jurisdictions. Interest paid was Euro (62.0) million and Euro (63.3) million in the first nine months of 2014 and 2013, respectively.
Investing activities. Our cash used in investing activities was Euro (311.2) million for the first nine months of 2014 as compared to Euro (341.1) million for the same period in 2013. The cash used in investing activities in the first nine months of 2014 primarily consisted of (i) Euro (177.3) million in capital expenditures mainly related to routine technology upgrades to the manufacturing infrastructure, opening of new stores and the remodeling of older stores with leases that were extended during the period, (ii) Euro (94.6) million for the acquisition of intangible assets related to the creation of a new IT platform, and (iii) Euro (39.4) million (net of cash acquired), related to the acquisition of glasses.com for Euro (29.5) million and other minor acquisitions in the retail segment for Euro (9.9) million. Cash used in investing activities in the first nine months of 2013 primarily consisted of (i) Euro (171.4) million in capital expenditures, mainly related to routine technology upgrades to the manufacturing infrastructure, opening of new stores and the remodeling of older stores with leases that were extended during the period, (ii) Euro (66.9) million for the acquisition of intangible assets, (iii) Euro (59.7) million (net of cash
16
acquired), mainly related to the acquisition of Alain Mikli International, and (iv) Euro (45.0) million, related to the acquisition of a 36.33 percent stake in Salmoiraghi & Viganò.
Financing activities. Our cash provided by/(used) in financing activities for the first nine months of 2014 and 2013 was Euro 11.1 million and Euro (564.2) million, respectively. Cash provided by/(used in) financing activities for the first nine months of 2014 consisted primarily of (i) Euro 500 million related to the issuance of a new bond, (ii) Euro (318.3) million related to the payment of existing debt, (iii) Euro (308.3) million used to pay dividends to the shareholders of the Company and (iii) Euro 55.5 million related to the exercise of stock options. Cash provided by/(used in) financing activities for the first nine months of 2013 consisted primarily of (i) Euro (328.5) million in cash used to repay short and long-term debt expiring during the first nine months of 2013, (ii) Euro (277.0) million used to pay dividends to the shareholders of the Company and (iii) Euro 72.5 million related to the exercise of stock options.
17
OUR CONSOLIDATED STATEMENT OF FINANCIAL POSITION
ASSETS (Amounts in thousands of Euro) |
September 30, 2014 (unaudited) |
December 31, 2013 (audited) |
|||||
---|---|---|---|---|---|---|---|
CURRENT ASSETS: |
|||||||
Cash and cash equivalents |
1,298,049 | 617,995 | |||||
Accounts receivablenet |
791,998 | 680,296 | |||||
Inventoriesnet |
708,252 | 698,950 | |||||
Other assets |
229,535 | 238,761 | |||||
| | | | | | | |
Total current assets |
3,027,834 | 2,236,002 | |||||
NON-CURRENT ASSETS: |
|||||||
Property, plant and equipmentnet |
1,259,520 | 1,183,236 | |||||
Goodwill |
3,282,865 | 3,045,216 | |||||
Intangible assetsnet |
1,350,051 | 1,261,137 | |||||
Investments |
58,705 | 58,108 | |||||
Other assets |
114,661 | 126,583 | |||||
Deferred tax assets |
200,877 | 172,623 | |||||
| | | | | | | |
Total non-current assets |
6,266,679 | 5,846,903 | |||||
| | | | | | | |
TOTAL ASSETS |
9,294,513 | 8,082,905 | |||||
| | | | | | | |
LIABILITIES AND STOCKHOLDERS' EQUITY |
September 30, 2014 (unaudited) |
December 31, 2013 (audited) |
|||||
---|---|---|---|---|---|---|---|
CURRENT LIABILITIES: |
|||||||
Short term borrowings |
122,811 | 44,921 | |||||
Current portion of long-term debt |
103,794 | 318,100 | |||||
Accounts payable |
712,080 | 681,151 | |||||
Income taxes payable |
144,761 | 9,477 | |||||
Short term provisions for risks and other charges |
145,233 | 123,688 | |||||
Other liabilities |
552,587 | 523,050 | |||||
| | | | | | | |
Total current liabilities |
1,781,266 | 1,700,386 | |||||
NON-CURRENT LIABILITIES: |
|||||||
Long-term debt |
2,190,107 | 1,716,410 | |||||
Employee benefits |
100,038 | 76,399 | |||||
Deferred tax liabilities |
259,156 | 268,078 | |||||
Long term provisions for risks and other charges |
109,764 | 97,544 | |||||
Other liabilities |
82,091 | 74,151 | |||||
| | | | | | | |
Total non-current liabilities |
2,741,156 | 2,232,583 | |||||
STOCKHOLDERS' EQUITY: |
|||||||
Luxottica Group stockholders' equity |
4,763,948 | 4,142,828 | |||||
Non-controlling interests |
8,142 | 7,107 | |||||
| | | | | | | |
Total stockholders' equity |
4,772,090 | 4,149,936 | |||||
| | | | | | | |
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY |
9,294,513 | 8,082,905 | |||||
| | | | | | | |
As of September 30, 2014, total assets increased by Euro 1,211.6 million to Euro 9,294.5 million, compared to Euro 8,082.9 million as of December 31, 2013.
18
In the first nine months of 2014, non-current assets increased by Euro 419.8 million, due to increases in intangible assets (including goodwill) of Euro 326.6 million, in tangible assets of Euro 76.3 million and deferred tax assets of Euro 28.3 million, partially offset by decreases in other assets of Euro 11.9 million.
The increase in intangible assets was due to capitalized software and other intangible asset additions of Euro 94.6 million, acquisitions that occurred in the first nine months of 2014 of Euro 35.0 million, effects of foreign currency fluctuations from December 2013 to September 2014 of Euro 308.5 million, which were partially offset by amortization of assets in the period of Euro 115.3 million.
The increase in property, plant and equipment was due to additions in the period of Euro 177.3 million, to the impact of foreign currency fluctuations from December 2013 to September 2014 of Euro 72.8 million, to the acquisitions that occurred in the first nine months of 2014 of Euro 5.5 million, which were partially offset by depreciation for the period of Euro 164.7 million and to disposals for the period of Euro 10.1 million.
As of September 30, 2014 as compared to December 31, 2013:
Our net financial position as of September 30, 2014 and December 31, 2013 was as follows:
(Amounts in thousands of Euro) |
September 30, 2014 (unaudited) |
December 31, 2013 (audited) |
|||||
---|---|---|---|---|---|---|---|
Cash and cash equivalents |
1,298,049 | 617,995 | |||||
Bank overdrafts |
(122,811 | ) | (44,921 | ) | |||
Current portion of long-term debt |
(103,794 | ) | (318,100 | ) | |||
Long-term debt |
(2,190,107 | ) | (1,716,410 | ) | |||
| | | | | | | |
Total |
(1,118,663 | ) | (1,461,435 | ) | |||
Bank overdrafts consist of the utilized portion of short-term uncommitted revolving credit lines borrowed by various subsidiaries of the Group and the applicable interest rate is usually variable and depends on the currency in which the loan is drawn.
As of September 30, 2014, Luxottica together with our wholly-owned Italian subsidiaries, had credit lines aggregating Euro 360.3 million. The interest rate is a floating rate of EURIBOR plus a margin on average of approximately 100 basis points. At September 30, 2014, Euro 0.1 million was utilized under these credit lines.
As of September 30, 2014, our wholly-owned subsidiary Luxottica U.S. Holdings Corp. maintained unsecured lines of credit with an aggregate maximum availability of Euro 98.0 million (USD 130.0 million). At September 30, 2014, Euro 4.9 million was utilized under these credit lines.
Euro 45.0 million in aggregate at September 30, 2014 face amount of standby letters of credit were outstanding related to guarantees on these lines of credit.
19
4. RELATED PARTY TRANSACTIONS
Our related party transactions are neither atypical nor unusual and occur in the ordinary course of our business. Management believes that these transactions are fair to the Company. For further details regarding related party transactions, please refer to Note 29 to the Condensed Consolidated Financial Statements as of September 30, 2014 (unaudited).
On January 29, 2013, the Company elected to avail itself of the options provided by Article 70, Section 8, and Article 71, Section 1- bis, of CONSOB Issuers' Regulations and, consequently, will no longer comply with the obligation to make available to the public an information memorandum in connection with transactions involving significant mergers, spin-offs, increases in capital through contributions in kind, acquisitions and disposals.
On April 29, 2014, the Board of Directors of Luxottica Group authorized the Company to enter into an agreement to lease a building located in Piazzale Cadorna 3, Milan. The lease will be for a period of seven years and 5 months and will be renewable for an additional six years.
The building is owned by Beni Stabili SIIQ S.p.A., which through Delfin S.àr.l, is ultimately controlled by the Company's Chairman Leonardo Del Vecchio, and therefore the lease agreement is a transaction with related parties. In accordance with the procedure on related parties adopted by the Company and Consob regulation n. 17221/2010 and in light of the contract balance, the agreement qualifies as a minor transaction with related parties.
On March 31, 2014 the Risk and Control Committee, solely composed of independent directors, unanimously expressed a favorable opinion regarding the Company's interest in entering in such transaction as well as on the convenience and fairness of the related conditions.
On September 1, 2014, following a period of debate with Chairman Leonardo Del Vecchio over the Group's future strategy and direction, Andrea Guerra left as Group CEO ("Former Group CEO") and received a termination payment in connection with his departure.
5. SUBSEQUENT EVENTS
For further details regarding subsequent events, please refer to Note 35 to the Condensed Consolidated Financial Statements as of September 30, 2014 (unaudited).
6. 2014 OUTLOOK
The financial results reported for the first nine months of 2014 lead management to an optimistic outlook for the full fiscal year.
NON-IFRS MEASURES
Adjusted measures
In this Management Report we refer to certain performance measures that are not in accordance with IFRS. Such non-IFRS measures are not meant to be considered in isolation or as a substitute for items appearing on our financial statements prepared in accordance with IFRS. Rather, these non-IFRS measures should be used as a supplement to IFRS results to assist the reader in better understanding our operational performance.
Such measures are not defined terms under IFRS and their definitions should be carefully reviewed and understood by investors. Such non-IFRS measures are explained in detail and reconciled to their most comparable IFRS measures below.
In order to provide a supplemental comparison of current period results of operations to prior periods, we have adjusted for certain non-recurring transactions or events.
20
For the first nine months of 2014 we made adjustments to the following measures: Net sales, cost of sales, general and administrative expenses, operating income, operating margin, EBITDA and EBITDA margin, net income and earnings per share. We adjusted the above items, as appropriate, by excluding a non-recurring expense related to termination of the Former Group CEO of Euro 15.0 million (Euro 10.9 million net of the tax effect) and by including sales of the EyeMed division of Euro 22.7 million which, starting from the third quarter of 2014, are reported on a net in lieu of a gross basis.
In 2013, we made adjustments to the following measures: operating income, operating margin, EBITDA and EBITDA margin. We have also adjusted net income, earnings per share, operating expenses, selling expenses and general and administrative expenses. We adjusted the above items by excluding (i) non-recurring costs related to the reorganization of the Alain Mikli business for Euro 9.0 million (Euro 5.9 million net of the tax effect), (ii) costs related to the tax audit of Luxottica S.r.l. (fiscal year 2007) for Euro 26.7 million and (iii) costs related to the tax audit of Luxottica S.r.l. (fiscal years subsequent to 2007) for Euro 40.0 million.
The adjusted measures referenced above are not measures of performance in accordance with International Financial Reporting Standards (IFRS), as issued by the International Accounting Standards Board and endorsed by the European Union. The Group believes that these adjusted measures are useful to both management and investors in evaluating the Group's operating performance compared with that of other companies in its industry in order to provide a supplemental view of operations that exclude items that are unusual, infrequent or unrelated to our ongoing operations.
Non-IFRS measures such as EBITDA, EBITDA margin, free cash flows and the ratio of net debt to EBITDA are included in this Management Report in order to:
See the tables below for a reconciliation of the adjusted measures discussed above to their most directly comparable IFRS financial measures or, in case of adjusted EBITDA, to EBITDA which is also a non-IFRS measure.
Non-IAS/IFRS Measures: reconciliation between reported and adjusted P&L items.
|
9M14 | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Luxottica Group |
Net Sales |
Cost of sales |
EBITDA |
Operating Income |
Net Income |
EPS |
|||||||||||||
Reported |
5,785.3 | (1,955.4 | ) | 1,227.6 | 947.5 | 555.0 | 1.17 | ||||||||||||
> 2014 EyeMed Adjustment |
22.7 | (22.7 | ) | | | | | ||||||||||||
>Adjustment for Former Group CEO payment |
| | 15.0 | 15.0 | 10.9 | 0.02 | |||||||||||||
| | | | | | | | | | | | | | | | | | | |
Adjusted |
5,808.0 | (1,978.0 | ) | 1,242.6 | 962.5 | 565.9 | 1.19 | ||||||||||||
21
|
9M14 | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Retail division |
Net Sales |
Cost of sales |
EBITDA |
Operating Income |
Net Income |
EPS |
|||||||||||||
Reported |
3,295.8 | (973.0 | ) | 620.4 | 487.7 | n/a | n/a | ||||||||||||
> 2014 EyeMed Adjustment |
22.7 | (22.7 | ) | | | | | ||||||||||||
Adjusted |
3,318.4 | (995.7 | ) | 620.4 | 487.7 | n/a | n/a | ||||||||||||
|
9M13 | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Luxottica Group |
Net Sales |
EBITDA |
Operating Income |
Net Income |
EPS |
|||||||||||
Reported |
5,666.7 | 1,165.9 | 891.6 | 518.8 | 1.10 | |||||||||||
> Adjustment for Alain Mikli restructuring |
| 9.0 | 9.0 | 5.9 | 0.01 | |||||||||||
Adjusted |
5,666.7 | 1,174.9 | 900.6 | 524.7 | 1.11 | |||||||||||
|
3Q14 | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Luxottica Group |
Net Sales |
Cost of sales |
EBITDA |
Operating Income |
Net Income |
EPS |
|||||||||||||
Reported |
1,883.0 | (605.6 | ) | 379.5 | 281.2 | 162.4 | 0.34 | ||||||||||||
> 2014 EyeMed Adjustment |
22.7 | (22.7 | ) | | | | | ||||||||||||
>Adjustment for Former Group CEO payment |
| | 15.0 | 15.0 | 10.9 | 0.02 | |||||||||||||
| | | | | | | | | | | | | | | | | | | |
Adjusted |
1,905.7 | (628.2 | ) | 394.5 | 296.2 | 173.3 | 0.36 | ||||||||||||
|
3Q14 | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Retail division |
Net Sales |
Cost of sales |
EBITDA |
Operating Income |
Net Income |
EPS |
|||||||||||||
Reported |
1,132.8 | (311.3 | ) | 227.8 | 180.9 | n/a | n/a | ||||||||||||
> 2014 EyeMed Adjustment |
22.7 | (22.7 | ) | | | | | ||||||||||||
Adjusted |
1,155.5 | (334.0 | ) | 227.8 | 180.9 | n/a | n/a | ||||||||||||
EBITDA and EBITDA margin
EBITDA represents net income attributable to Luxottica Group stockholders, before non-controlling interest, provision for income taxes, other income/expense, depreciation and amortization. EBITDA margin means EBITDA divided by net sales. We believe that EBITDA is useful to both management and investors in evaluating our operating performance compared to that of other companies in our industry. Our calculation of EBITDA allows us to compare our operating results with those of other companies without giving effect to financing, income taxes and the accounting effects of capital spending, which items may vary for different companies for reasons unrelated to the overall operating performance of a company's business. For additional information on Group's non-IFRS measures used in this report, see "NON-IFRS MEASURESAdjusted Measures" set forth above.
EBITDA and EBITDA margin are not meant to be considered in isolation or as a substitute for items appearing on our financial statements prepared in accordance with IFRS. Rather, these non-IFRS measures should be used as a supplement to IFRS results to assist the reader in better understanding the operational performance of the Group.
22
The Group cautions that these measures are not defined terms under IFRS and their definitions should be carefully reviewed and understood by investors.
Investors should be aware that our method of calculating EBITDA may differ from methods used by other companies. We recognize that the usefulness of EBITDA has certain limitations, including:
We compensate for the foregoing limitations by using EBITDA as a comparative tool, together with IFRS measurements, to assist in the evaluation of our operating performance and leverage. The following table provides a reconciliation of EBITDA to net income, which is the most directly comparable IFRS financial measure, as well as the calculation of EBITDA margin on net sales:
Non-IAS/IFRS Measure: EBITDA and EBITDA margin
Millions of Euro |
3Q 2013 |
3Q 2014 |
9M 2013 |
9M 2014 |
FY 2013 |
LTM September 2014 |
|||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net income/(loss) |
147.6 | 162.4 | 518.8 | 555.0 | 544.7 | 580.9 | |||||||||||||
(+) |
|||||||||||||||||||
Net income attributable to non-controlling interest |
0.9 |
0.7 |
3.8 |
4.0 |
4.2 |
4.4 |
|||||||||||||
(+) |
|||||||||||||||||||
Provision for income taxes |
83.4 |
93.7 |
293.9 |
316.4 |
407.5 |
430.0 |
|||||||||||||
(+) |
|||||||||||||||||||
Other (income)/expense |
23.2 |
24.3 |
75.1 |
72.1 |
99.3 |
96.3 |
|||||||||||||
(+) |
|||||||||||||||||||
Depreciation and amortization |
91.8 |
98.3 |
274.3 |
280.0 |
366.6 |
372.3 |
|||||||||||||
(+) |
|||||||||||||||||||
EBITDA |
346.9 |
379.5 |
1,165.9 |
1,227.6 |
1,422.3 |
1,484.0 |
|||||||||||||
(=) |
|||||||||||||||||||
Net sales |
1,785.0 |
1,883.0 |
5,666.7 |
5,785.3 |
7,312.6 |
7,431.2 |
|||||||||||||
(/) |
|||||||||||||||||||
EBITDA margin |
19.4 |
% |
20.2 |
% |
20.6 |
% |
21.2 |
% |
19.5 |
% |
20.0 |
% |
|||||||
(=) |
|||||||||||||||||||
23
Non-IAS/IFRS Measure: Adjusted EBITDA and Adjusted EBITDA margin
Millions of Euro |
3Q 2013 |
3Q 2014(3)(4) |
9M 2013(2) |
9M 2014(3)(4) |
FY 2013(1)(2) |
LTM September 2014(1)(2)(3)(4) |
|||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Adjusted net income/(loss) |
147.6 | 173.3 | 524.7 | 565.9 | 617.3 | 658.5 | |||||||||||||
(+) |
|||||||||||||||||||
Net income attributable to non-controlling interest |
0.9 |
0.7 |
3.8 |
4.0 |
4.2 |
4.4 |
|||||||||||||
(+) |
|||||||||||||||||||
Adjusted provision for income taxes |
83.4 |
97.8 |
297.0 |
320.5 |
343.9 |
367.4 |
|||||||||||||
(+) |
|||||||||||||||||||
Other (income)/expense |
23.2 |
24.3 |
75.1 |
72.1 |
99.3 |
96.3 |
|||||||||||||
(+) |
|||||||||||||||||||
Depreciation and amortization |
91.8 |
98.3 |
274.3 |
280.0 |
366.6 |
372.3 |
|||||||||||||
(+) |
|||||||||||||||||||
Adjusted EBITDA |
346.9 |
394.5 |
1,174.9 |
1,242.6 |
1,431.3 |
1,499.0 |
|||||||||||||
(=) |
|||||||||||||||||||
Net sales |
1,785.0 |
1,905.6 |
5,666.7 |
5,808.0 |
7,312.6 |
7,453.9 |
|||||||||||||
(/) |
|||||||||||||||||||
Adjusted EBITDA margin |
19.4 |
% |
20.7 |
% |
20.7 |
% |
21.4 |
% |
19.6 |
% |
20.1 |
% |
|||||||
(=) |
|||||||||||||||||||
The adjusted figures:
Free Cash Flow
Free cash flow represents EBITDA, as defined above, plus or minus the decrease/(increase) in working capital over the period, less capital expenditures, plus or minus interest income/(expense) and extraordinary items, minus taxes paid. Our calculation of free cash flow provides a clearer picture of our ability to generate net cash from operations, which is used for mandatory debt service requirements, to fund discretionary investments, pay dividends or pursue other strategic opportunities. Free cash flow is not meant to be considered in isolation or as a substitute for items appearing on our financial statements prepared in accordance with IFRS. Rather, this non-IFRS measure should be used as a supplement to IFRS results to assist the reader in better understanding the operational performance of the Group. For additional information on Group's non-IFRS measures used in this report, see "NON-IFRS MEASURESAdjusted Measures" set forth above.
24
The Group cautions that this measure is not a defined term under IFRS and its definition should be carefully reviewed and understood by investors.
Investors should be aware that our method of calculation of free cash flow may differ from methods used by other companies. We recognize that the usefulness of free cash flow as an evaluative tool may have certain limitations, including:
We compensate for the foregoing limitations by using free cash flow as one of several comparative tools, together with IFRS measurements, to assist in the evaluation of our operating performance.
The following table provides a reconciliation of free cash flow to EBITDA and the table above provides a reconciliation of EBITDA to net income, which is the most directly comparable IFRS financial measure:
Non-IFRS Measure: Free cash flow
(Amounts in millions of Euro) |
9M 2014 |
|||
---|---|---|---|---|
Adjusted EBITDA(1) |
1,243 | |||
D working capital |
(20 | ) | ||
Capex |
(270 | ) | ||
| | | | |
Operating cash flow |
953 | |||
Financial charges(2) |
(72 | ) | ||
Taxes |
(184 | ) | ||
Othernet |
| |||
| | | | |
Free cash flow |
697 | |||
(Amounts in millions of Euro) |
3Q 2014 |
|||
---|---|---|---|---|
Adjusted EBITDA(1) |
395 | |||
D working capital |
92 | |||
Capex |
(96 | ) | ||
| | | | |
Operating cash flow |
390 | |||
Financial charges(2) |
(24 | ) | ||
Taxes |
(50 | ) | ||
Othernet |
| |||
| | | | |
Free cash flow |
316 | |||
25
Net debt to EBITDA ratio
Net debt represents the sum of bank overdrafts, the current portion of long-term debt and long-term debt, less cash. The ratio of net debt to EBITDA is a measure used by management to assess the Group's level of leverage, which affects our ability to refinance our debt as it matures and incur additional indebtedness to invest in new business opportunities. The ratio also allows management to assess the cost of existing debt since it affects the interest rates charged by the Company's lenders.
EBITDA, as defined above, and the ratio of net debt to EBITDA are not meant to be considered in isolation or as a substitute for items appearing on our financial statements prepared in accordance with IFRS. Rather, these non-IFRS measures should be used as a supplement to IFRS results to assist the reader in better understanding the operational performance of the Group. For additional information on Group's non-IFRS measures used in this report, see "NON-IFRS MEASURESAdjusted Measures" set forth above.
The Group cautions that these measures are not defined terms under IFRS and their definitions should be carefully reviewed and understood by investors.
Investors should be aware that Luxottica Group's method of calculating EBITDA and the ratio of net debt to EBITDA may differ from methods used by other companies.
The Group recognizes that the usefulness of the ratio of net debt to EBITDA as evaluative tool may have certain limitations, including that the ratio of net debt to EBITDA is net of cash and cash equivalents, restricted cash and short-term investments, thereby reducing our debt position.
Because we may not be able to use our cash to reduce our debt on a dollar-for-dollar basis, this measure may have material limitations. We compensate for the foregoing limitations by using EBITDA and the ratio of net debt to EBITDA as two of several comparative tools, together with IFRS measurements, to assist in the evaluation of our operating performance and leverage.
See the table below for a reconciliation of net debt to long-term debt, which is the most directly comparable IFRS financial measure, as well as the calculation of the ratio of net debt to EBITDA. For a reconciliation of EBITDA to its most directly comparable IFRS measure, see the table on the earlier page.
Non-IFRS Measure: Net debt and Net debt/EBITDA
(Amounts in millions of Euro) |
September 30, 2014 |
FY 2013 |
|||||
---|---|---|---|---|---|---|---|
Long-term debt |
2,190.1 | 1,716.4 | |||||
(+) |
|||||||
Current portion of long-term debt |
103.8 |
318.1 |
|||||
(+) |
|||||||
Bank overdrafts |
122.8 |
44.9 |
|||||
(+) |
|||||||
Cash |
(1,298.0 |
) |
(618.0 |
) |
|||
(-) |
|||||||
Net debt |
1,118.7 |
1,461.4 |
|||||
(=) |
|||||||
LTM EBITDA |
1,484.0 |
1,422.3 |
|||||
Net debt/EBITDA |
0.8 |
x |
1.0 |
x |
|||
Net debt @ avg. exchange rates(1) |
1,104.7 |
1,475.9 |
|||||
Net debt @ avg. exchange rates(1)/EBITDA |
0.7 |
x |
1.0 |
x |
|||
26
Non-IFRS Measure: Net debt and Net debt/Adjusted EBITDA
(Amounts in millions of Euro) |
September 30, 2014(3) |
FY 2013(2) |
|||||
---|---|---|---|---|---|---|---|
Long-term debt |
2,190.1 | 1,716.4 | |||||
(+) |
|||||||
Current portion of long-term debt |
103.8 |
318.1 |
|||||
(+) |
|||||||
Bank overdrafts |
122.8 |
44.9 |
|||||
(+) |
|||||||
Cash |
(1,298.0 |
) |
(618.0 |
) |
|||
(-) |
|||||||
Net debt |
1,118.7 |
1,461.4 |
|||||
(=) |
|||||||
LTM Adjusted EBITDA |
1,499.0 |
1,431.3 |
|||||
Net debt/LTM Adjusted EBITDA |
0.7 |
x |
1.0 |
x |
|||
Net debt @ avg. exchange rates(1) |
1,104.7 |
1,475.9 |
|||||
Net debt @ avg. exchange rates(1)/LTM EBITDA |
0.7 |
x |
1.0 |
x |
|||
FORWARD-LOOKING INFORMATION
Throughout this report, management has made certain "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 which are considered prospective. These statements are made based on management's current expectations and beliefs and are identified by the use of forward-looking words and phrases such as "plans," "estimates," "believes" or "belief," "expects" or other similar words or phrases.
Such statements involve risks, uncertainties and other factors that could cause actual results to differ materially from those which are anticipated. Such risks and uncertainties include, but are not limited to, our ability to manage the effect of the uncertain current global economic conditions on our business, our ability to successfully acquire new businesses and integrate their operations, our ability to predict future economic conditions and changes in consumer preferences, our ability to successfully introduce and market new products, our ability to maintain an efficient distribution network, our ability to achieve and manage growth, our ability to negotiate and maintain favorable license arrangements, the availability of correction alternatives to prescription eyeglasses, fluctuations in exchange rates, changes in local conditions, our ability to protect our proprietary rights, our ability to maintain our relationships with host stores, any failure of our information technology, inventory and other asset risk, credit risk on our accounts, insurance risks, changes in tax laws, as well as other political, economic, legal and technological factors and other risks and uncertainties described in our filings with the U.S. Securities and Exchange Commission. These forward-looking statements are made as of the date hereof, and we do not assume any obligation to update them.
27
CONSOLIDATED STATEMENT OF FINANCIAL POSITION
(Amounts in thousands of Euro) |
Note reference |
September 30, 2014 (unaudited) |
Of which related parties (note 29) |
December 31, 2013 (audited) |
Of which related parties (note 29) |
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ASSETS |
||||||||||||||||
CURRENT ASSETS: |
||||||||||||||||
Cash and cash equivalents |
6 | 1,298,049 | | 617,995 | | |||||||||||
Accounts receivable |
7 | 791,998 | 15,198 | 680,296 | 11,616 | |||||||||||
Inventories |
8 | 708,252 | | 698,950 | | |||||||||||
Other assets |
9 | 229,535 | 3,107 | 238,761 | 931 | |||||||||||
| | | | | | | | | | | | | | | | |
Total current assets |
3,027,834 | 18,305 | 2,236,002 | 12,547 | ||||||||||||
NON-CURRENT ASSETS: |
||||||||||||||||
Property, plant and equipment |
10 | 1,259,520 | | 1,183,236 | | |||||||||||
Goodwill |
11 | 3,282,865 | | 3,045,216 | | |||||||||||
Intangible assets |
11 | 1,350,051 | | 1,261,137 | | |||||||||||
Investments |
12 | 58,705 | 49,083 | 58,108 | 49,097 | |||||||||||
Other assets |
13 | 114,661 | | 126,583 | 778 | |||||||||||
Deferred tax assets |
14 | 200,877 | | 172,623 | | |||||||||||
| | | | | | | | | | | | | | | | |
Total non-current assets |
6,266,679 | 49,083 | 5,846,903 | 49,875 | ||||||||||||
TOTAL ASSETS |
9,294,513 | 67,387 | 8,082,905 | 62,422 | ||||||||||||
LIABILITIES AND STOCKHOLDERS' EQUITY |
||||||||||||||||
CURRENT LIABILITIES: |
||||||||||||||||
Short-term borrowings |
15 | 122,811 | | 44,921 | | |||||||||||
Current portion of long-term debt |
16 | 103,794 | | 318,100 | | |||||||||||
Accounts payable |
17 | 712,080 | 11,782 | 681,151 | 10,067 | |||||||||||
Income taxes payable |
18 | 144,761 | | 9,477 | | |||||||||||
Short term provisions for risks and other charges |
19 | 145,233 | | 123,688 | | |||||||||||
Other liabilities |
20 | 552,587 | 11,960 | 523,050 | 27 | |||||||||||
| | | | | | | | | | | | | | | | |
Total current liabilities |
1,781,266 | 23,742 | 1,700,386 | 10,095 | ||||||||||||
NON-CURRENT LIABILITIES: |
||||||||||||||||
Long-term debt |
21 | 2,190,107 | | 1,716,410 | | |||||||||||
Employee benefits |
22 | 100,038 | | 76,399 | | |||||||||||
Deferred tax liabilities |
14 | 259,156 | | 268,078 | | |||||||||||
Long term provisions for risks and other charges |
23 | 109,764 | | 97,544 | | |||||||||||
Other liabilities |
24 | 82,091 | | 74,151 | | |||||||||||
| | | | | | | | | | | | | | | | |
Total non-current liabilities |
2,741,156 | | 2,232,583 | | ||||||||||||
STOCKHOLDERS' EQUITY: |
||||||||||||||||
Capital stock |
25 | 28,844 | | 28,653 | | |||||||||||
Legal reserve |
25 | 5,736 | | 5,711 | | |||||||||||
Reserves |
25 | 4,248,263 | | 3,646,830 | | |||||||||||
Treasury shares |
25 | (73,875 | ) | | (83,060 | ) | | |||||||||
Net income |
25 | 554,982 | | 544,696 | | |||||||||||
| | | | | | | | | | | | | | | | |
Luxottica Group stockholders' equity |
25 | 4,763,948 | | 4,142,828 | | |||||||||||
Non-controlling interests |
26 | 8,142 | | 7,107 | | |||||||||||
| | | | | | | | | | | | | | | | |
Total stockholders' equity |
4,772,090 | | 4,149,936 | | ||||||||||||
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY |
9,294,513 | 23,742 | 8,082,905 | 10,095 | ||||||||||||
28
CONSOLIDATED STATEMENT OF INCOME
(Amounts in thousands of Euro)(1) |
Note reference |
Nine Months ended September 30, 2014 (unaudited) |
Of which related parties (note 29) |
Nine Months ended September 30, 2013 (unaudited) |
Of which related parties (note 29) |
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales |
27 | 5,785,282 | 18,725 | 5,666,720 | 12,750 | |||||||||||
Cost of sales |
27 | 1,955,366 | 38,078 | 1,930,969 | 33,493 | |||||||||||
Gross profit |
3,829,916 | (19,353 | ) | 3,735,751 | (20,742 | ) | ||||||||||
| | | | | | | | | | | | | | | | |
Selling |
27 | 1,710,560 | | 1,697,999 | 19 | |||||||||||
Royalties |
27 | 112,352 | 694 | 109,105 | 730 | |||||||||||
Advertising |
27 | 381,202 | 50 | 364,919 | 9 | |||||||||||
General and administrative |
27 | 678,260 | 12,252 | 672,132 | 291 | |||||||||||
of which nonrecurring |
33 | 15,000 | | 9,000 | | |||||||||||
| | | | | | | | | | | | | | | | |
Total operating expenses |
2,882,375 | 12,998 | 2,844,155 | 1,048 | ||||||||||||
| | | | | | | | | | | | | | | | |
Income from operations |
947,541 | (32,352 | ) | 891,596 | (21,791 | ) | ||||||||||
| | | | | | | | | | | | | | | | |
Other income/(expense) |
||||||||||||||||
Interest income |
27 | 8,994 | | 6,652 | | |||||||||||
Interest expense |
27 | (80,764 | ) | | (76,872 | ) | | |||||||||
Othernet |
27 | (367 | ) | 1 | (4,911 | ) | 2 | |||||||||
| | | | | | | | | | | | | | | | |
Income before provision for income taxes |
875,405 | (32,350 | ) | 816,466 | (21,789 | ) | ||||||||||
| | | | | | | | | | | | | | | | |
Provision for income taxes |
27 | (316,373 | ) | | (293,919 | ) | | |||||||||
of which nonrecurring |
33 | 4,125 | | 3,096 | | |||||||||||
| | | | | | | | | | | | | | | | |
Net income |
559,031 | | 522,547 | | ||||||||||||
| | | | | | | | | | | | | | | | |
Of which attributable to: |
||||||||||||||||
Luxottica Group stockholders |
554,982 | | 518,755 | | ||||||||||||
Non-controlling interests |
4,049 | | 3,792 | | ||||||||||||
| | | | | | | | | | | | | | | | |
NET INCOME |
559,031 | | 522,547 | | ||||||||||||
| | | | | | | | | | | | | | | | |
Weighted average number of shares outstanding: |
||||||||||||||||
Basic |
30 | 475,325,386 | 471,617,863 | |||||||||||||
Diluted |
30 | 478,351,143 | 476,031,873 | |||||||||||||
EPS: |
||||||||||||||||
Basic |
30 | 1.17 | 1.10 | |||||||||||||
Diluted |
30 | 1.16 | 1.09 |
29
CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME
(Amounts in thousands of Euro) |
Nine Months ended September 30, 2014 (unaudited) |
Nine Months ended September 30, 2013 (unaudited) |
|||||
---|---|---|---|---|---|---|---|
Net income |
559,031 | 522,547 | |||||
Other comprehensive income: |
|||||||
Items that may be reclassified subsequently to profit or loss: |
|||||||
Cash flow hedgenet of tax of Euro 0.0 million and 0.1 million as of September 30, 2014 and September 30, 2013, respectively |
| 318 | |||||
Currency translation differences |
311,373 | (179,666 | ) | ||||
| | | | | | | |
Total items that may be reclassified subsequently to profit or loss: |
311,373 | (179,348 | ) | ||||
| | | | | | | |
Items that will not be reclassified to profit or loss: |
|||||||
Actuarial (loss)/gain on defined benefit plansnet of tax of Euro 19.8 million and Euro 32.5 million as of September 30, 2014 and September 30, 2013, respectively |
(25,662 | ) | 65,428 | ||||
| | | | | | | |
Total items that will not be reclassified to profit or loss |
(25,662 | ) | 65,428 | ||||
| | | | | | | |
Total other comprehensive incomenet of tax |
285,711 | (113,920 | ) | ||||
| | | | | | | |
Total comprehensive income for the period |
844,742 | 408,627 | |||||
| | | | | | | |
Attributable to: |
|||||||
Luxottica Group stockholders |
840,388 | 406,209 | |||||
Non-controlling interests |
4,354 | 2,418 | |||||
| | | | | | | |
Total comprehensive income for the period |
844,742 | 408,627 | |||||
| | | | | | | |
| | | | | | | |
30
CONSOLIDATED STATEMENT OF CHANGES IN EQUITY
FOR THE PERIODS ENDED SEPTEMBER 30, 2014 AND 2013 (UNAUDITED)
|
Capital stock | |
|
|
|
|
|
|
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Legal reserve |
Additional paid-in capital |
Retained earnings |
Stock options reserve |
Translation of foreign operations and other |
Treasury shares |
Stockholders' equity |
Non- controlling interests |
|||||||||||||||||||||||
(Amounts in thousands of Euro, except share data) |
Number of shares |
Amount |
|||||||||||||||||||||||||||||
|
Note 25 |
Note 26 |
|||||||||||||||||||||||||||||
Balance as of January 1, 2013 |
473,238,197 | 28,394 | 5,623 | 328,742 | 3,633,481 | 241,286 | (164,224 | ) | (91,929 | ) | 3,981,372 | 11,868 | |||||||||||||||||||
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Total Comprehensive Income as of September 30, 2013 |
| | | | 584,500 | | (178,292 | ) | | 406,209 | 2,418 | ||||||||||||||||||||
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Exercise of stock options |
4,157,053 | 249 | | 72,283 | | | | | 72,532 | | |||||||||||||||||||||
Non-cash stock based compensation |
| | | | | 21,235 | | | 21,235 | | |||||||||||||||||||||
Excess tax benefit on stock options |
| | | 11,316 | | | | | 11,316 | | |||||||||||||||||||||
Granting of treasury shares to employees |
| | | | (8,869 | ) | | | 8,869 | | | ||||||||||||||||||||
Change in the consolidation perimeter |
| | | | (1,076 | ) | | | | (1,076 | ) | | |||||||||||||||||||
Dividends (Euro 0.58 per ordinary share) |
| | | | (273,689 | ) | | | | (273,689 | ) | (3,335 | ) | ||||||||||||||||||
Allocation of legal reserve |
| | 88 | | (88 | ) | | | | | | ||||||||||||||||||||
Balance as of September 30, 2013 |
477,395,250 | 28,643 | 5,711 | 412,341 | 3,934,259 | 262,521 | (342,516 | ) | (83,060 | ) | 4,217,899 | 10,951 | |||||||||||||||||||
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Balance as of January 1, 2014 |
477,560,673 | 28,653 | 5,711 | 412,063 | 3,958,076 | 268,833 | (447,447 | ) | (83,060 | ) | 4,142,828 | 7,107 | |||||||||||||||||||
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Total Comprehensive Income as of September 30, 2014 |
| | | | 529,307 | | 311,081 | | 840,388 | 4,354 | |||||||||||||||||||||
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Exercise of stock options |
3,174,345 | 190 | | 55,325 | | | | | 55,515 | | |||||||||||||||||||||
Non-cash stock based compensation |
| | | | | 29,856 | | | 29,856 | | |||||||||||||||||||||
Excess tax benefit on stock options |
| | | 3,704 | | | | | 3,704 | | |||||||||||||||||||||
Granting of treasury shares to employees |
| | | | (9,185 | ) | | | 9,185 | | | ||||||||||||||||||||
Dividends (Euro 0.65 per ordinary share) |
| | | | (308,343 | ) | | | | (308,343 | ) | (3,319 | ) | ||||||||||||||||||
Allocation of legal reserve |
| | 24 | | (24 | ) | | | | | | ||||||||||||||||||||
Balance as of September 30, 2014 |
480,735,018 | 28,844 | 5,736 | 471,092 | 4,169,830 | 298,689 | (136,366 | ) | (73,875 | ) | 4,763,948 | 8,142 | |||||||||||||||||||
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
31
CONSOLIDATED STATEMENT OF CASH FLOWS
(Amounts in thousands of Euro) |
Note reference |
September 30, 2014 (unaudited) |
September 30, 2013 (unaudited) |
|||||||
---|---|---|---|---|---|---|---|---|---|---|
Income before provision for income taxes |
875,405 | 816,466 | ||||||||
| | | | | | | | | | |
Stock-based compensation |
29,856 | 21,771 | ||||||||
Depreciation and amortization |
10/11 | 280,023 | 274,319 | |||||||
Net loss fixed assets and other |
10 | 10,053 | 5,210 | |||||||
Financial charges |
80,764 | 75,109 | ||||||||
Other non-cash items |
107 | 1,436 | ||||||||
Changes in accounts receivable |
(79,153 | ) | (80,372 | ) | ||||||
Changes in inventories |
21,856 | 2,100 | ||||||||
Changes in accounts payable |
313 | (64,731 | ) | |||||||
Changes in other assets/liabilities |
(37,512 | ) | (69,647 | ) | ||||||
| | | | | | | | | | |
Total adjustments |
306,307 | 165,194 | ||||||||
| | | | | | | | | | |
Cash provided by operating activities |
1,181,712 | 981,660 | ||||||||
Interest paid |
(61,995 | ) | (63,277 | ) | ||||||
Tax paid |
(183,807 | ) | (238,497 | ) | ||||||
| | | | | | | | | | |
Net cash provided by operating activities |
935,910 | 679,866 | ||||||||
| | | | | | | | | | |
Additions of property, plant and equipment |
10 | (177,265 | ) | (171,374 | ) | |||||
Disposals of property, plant and equipment |
| 2,386 | ||||||||
Purchases of businessesnet of cash acquired(*) |
4 | (39,397 | ) | (59,680 | ) | |||||
Increase in investment(**) |
12 | | (45,597 | ) | ||||||
Additions to intangible assets |
11 | (94,565 | ) | (66,864 | ) | |||||
| | | | | | | | | | |
Cash used in investing activities |
(311,227 | ) | (341,128 | ) | ||||||
32
CONSOLIDATED STATEMENT OF CASH FLOWS
(Amounts in thousands of Euro) |
Note reference |
September 30, 2014 (unaudited) |
September 30, 2013 (unaudited) |
|||||||
---|---|---|---|---|---|---|---|---|---|---|
Long-term debt: |
||||||||||
Proceeds |
21 | 497,031 | 3,569 | |||||||
Repayments |
21 | (318,346 | ) | (328,537 | ) | |||||
Short-term debt: |
||||||||||
Proceeds |
88,531 | | ||||||||
Repayments |
| (34,727 | ) | |||||||
Exercise of stock options |
25 | 55,515 | 72,532 | |||||||
Dividends |
(311,662 | ) | (277,023 | ) | ||||||
| | | | | | | | | | |
Cash (used in)/provided financing activities |
11,069 | (564,186 | ) | |||||||
| | | | | | | | | | |
Increase/(decrease) in cash and cash equivalents |
635,752 | (225,429 | ) | |||||||
| | | | | | | | | | |
Cash and cash equivalents, beginning of the period |
617,995 | 790,093 | ||||||||
| | | | | | | | | | |
Effect of exchange rate changes on cash and cash equivalents |
44,302 | (26,946 | ) | |||||||
| | | | | | | | | | |
Cash and cash equivalents, end of the period |
1,298,049 | 537,718 | ||||||||
33
Luxottica Group S.p.A.
Headquarters and registered office Piazzale L. Cadorna 320123 Milan, Italy
Capital Stock: € 28,844,101.08
authorized and issued
Notes to the
CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
AS OF SEPTEMBER 30, 2014
(UNAUDITED)
1. BACKGROUND
Luxottica Group S.p.A. (hereinafter the "Company" or together with its consolidated subsidiaries, the "Group") is a company listed on Borsa Italiana and the New York Stock Exchange with its registered office located at Piazzale L. Cadorna 3, Milan (Italy), organized under the laws of the Republic of Italy.
The Company is controlled by Delfin S.à r.l., based in Luxembourg. The chairman of the Board of Directors of the Company, Leonardo Del Vecchio, controls Delfin S.à r.l..
In line with prior years, the retail division's fiscal year is a 52- or 53-week period ending on the Saturday nearest December 31. The use of a calendar fiscal year by these entities would not have had a material impact on the consolidated financial statements.
The Company's Board of Directors, at its meeting on October 29, 2014, approved the Group's interim condensed consolidated financial statements as of September 30, 2014 (hereinafter referred to as the "Financial Report") for publication.
The financial statements included in this Financial Report are unaudited.
2. BASIS OF PREPARATION
This Financial Report has been prepared in accordance with article 154- ter of the Legislative Decree No. 58 of February 24, 1998 and subsequent modifications and in accordance with the CONSOB Issuers Regulation in compliance with the International Financial Reporting Standards ("IFRS") issued by the International Accounting Standards Board ("IASB") and endorsed by the European Union in accordance with the regulation (CE) n. 1606/2002 of the European Parliament and of the Council of July 19, 2002. Furthermore, this financial report has been prepared in accordance with International Accounting Standard ("IAS") 34Interim Financial Reporting, and of the provisions which implement Article 9 of Legislative Decree no. 38/2005.
IFRS are all the international accounting standards ("IAS") and all the interpretations of the International Financial Reporting Interpretations Committee ("IFRIC"), previously named "Standing Interpretation Committee" (SIC).
In order to provide the reader of these condensed consolidated financial statements with a meaningful comparison of the information included in the condensed consolidated financial statements as of September 30, 2014, certain prior year comparative information has been revised to conform to the current year presentation. The revision relates to the reclassification of the warehouse and shipping expenses of certain subsidiaries of the Company from general and administrative expenses to cost of sales. The Company has determined that the revision, totaling Euro 30.5 million, is immaterial to the previously reported financial statements and does not impact any of the Group's key financial indicators.
This unaudited Financial Report should be read in connection with the consolidated financial statements as of December 31, 2013, which were prepared in accordance with IFRS, as endorsed by the European Union.
34
Notes to the
CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
AS OF SEPTEMBER 30, 2014
(UNAUDITED)
2. BASIS OF PREPARATION (Continued)
In accordance with IAS 34, the Group has chosen to publish a set of condensed financial statements in its financial report as of September 30, 2014.
The principles and standards used in the preparation of this unaudited Financial Report are consistent with those used in preparing the audited consolidated financial statements as of December 31, 2013, except as described in Note 3 "New Accounting Principles," and taxes on income which are accrued using the tax rate that would be applicable to projected total annual profit.
This Financial Report has been prepared on a going concern basis. Management believes that there are no indicators that may cast significant doubt upon the Group's ability to continue as a going concern, in particular, over the next twelve months.
The Company's reporting currency for the presentation of the consolidated financial statements is the Euro. Unless otherwise specified, the figures in the statements and within these Notes to the Condensed Consolidated Financial Statements are expressed in thousands of Euro.
This Financial Report is composed of the consolidated statements of financial position, the consolidated statements of income, the consolidated statements of comprehensive income, the consolidated statements of changes in equity, the consolidated statements of cash flows and Notes to the Condensed Consolidated Financial Statements as of September 30, 2014.
The financial statements were prepared using the historical cost convention, with the exception of certain financial assets and liabilities for which measurement at fair value is required.
The Group also applied the CONSOB resolution n. 15519 of July 27, 2006 and the CONSOB communication n. 6064293 of July 28, 2006.
The preparation of this report required management to use estimates and assumptions that affected the reported amounts of revenue, costs, assets and liabilities, as well as disclosures relating to contingent assets and liabilities at the reporting date. Results published on the basis of such estimates and assumptions could vary from actual results that may be realized in the future.
These measurement processes and, in particular, those that are more complex, such as the calculation of impairment losses on non-current assets, and the actuarial calculations necessary to calculate certain employee benefits liabilities, are generally carried out only when the audited consolidated financial statements for the fiscal year are prepared, unless there are indicators which require updates to estimates.
3. NEW ACCOUNTING PRINCIPLES
New standards and amendments that are effective for reporting periods beginning on or after January 1, 2014.
IFRIC 21Levies. The interpretation published by the IASB on May 20, 2013 is applicable to the periods starting from January 1, 2014. IFRIC 21 is an interpretation of IAS 37Provision, Contingent Liabilities and Contingent Assets, which requires that a provision is booked if, being certain other conditions met, an entity also has a present obligations as a consequence of a past event ("obligating event"). The interpretation clarifies the obligating event that requires an obligation to pay taxes to be recorded is the
35
Notes to the
CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
AS OF SEPTEMBER 30, 2014
(UNAUDITED)
3. NEW ACCOUNTING PRINCIPLES (Continued)
activity that determines the tax payments, as set forth by the law. The adoption of the interpretation did not have a significant impact on the consolidated financial statements of the Group.
Amendments to IAS 32Financial instruments: "Presentation on offsetting financial assets and financial liabilities." The amendments clarify some of the requirements for offsetting financial assets and financial liabilities on the balance sheet. The standard, published in December 2011, was endorsed by the European Union in December 2012 and is effective for annual periods beginning on or after January 1, 2014. The adoption of the standard did not have a significant impact on the consolidated financial statements of the Group.
Amendments to IAS 36Impairment of assets. The amendments address the disclosure of information about the recoverable amount of impaired assets if that amount is based on fair value less cost of disposals. The amendments are effective for annual periods beginning on or after January 1, 2014. The adoption of the amendments did not have a significant impact on the consolidated financial statements of the Group.
New standards and amendments that are effective for reporting periods beginning after January 1, 2014 and not early adopted.
IFRS 9Financial instruments, issued in November 2009. The standard is the first step in the process to replace IAS 39Financial instruments: recognition and measurement. IFRS 9 introduces new requirements for classifying and measuring financial assets. The new standard reduces the number of categories of financial assets pursuant to IAS 39 and requires that all financial assets be: (i) classified on the basis of the model which a company has adopted in order to manage its financial activities and on the basis of the cash flows from financing activities; (ii) initially measured at fair value plus any transaction costs in the case of financial assets not measured at fair value through profit and loss; and (iii) subsequently measured at their fair value or at the amortized cost. IFRS 9 also provides that embedded derivatives which fall within the scope of IFRS 9 must no longer be separated from the primary contract which contains them and states that a company may decide to directly recordwithin the consolidated statement of comprehensive incomeany changes in the fair value of investments which fall within the scope of IFRS 9. The standard has not yet been endorsed by the European Union. The Group has not early adopted and is assessing the full impact of adopting IFRS 9.
IFRS 15Revenue from contracts with customers, issued on May 28, 2014. The new standard will be effective for the first interim period within the annual reporting periods beginning on or after January 1, 2017. This standard replaces IAS 18Revenues, IAS 11Construction Contracts, IFRIC 13Customers Loyalty Programs, IFRIC 15Agreements for Constructions of Real Estate, IFRIC 18Transfers of Assets from Customers, SIC 31RevenueBarter Transactions Involving Advertising Services. Revenue is recognized when the customer obtains control over goods or services and, therefore, when it has the ability to direct the use of and obtain the benefit from them. In case an entity agrees to provide goods or services for consideration that varies upon certain future events occurring or not occurring, an estimate of this variable consideration is included in the transaction price only if highly probable. The consideration in multiple element transactions is allocated based on the price an entity would charge a customer on a stand-alone for each good or service. Entities sometimes incur costs, such as sales commissions, to obtain or fulfill a contract. Contract costs that meet certain criteria are capitalized as an asset and amortized as
36
Notes to the
CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
AS OF SEPTEMBER 30, 2014
(UNAUDITED)
3. NEW ACCOUNTING PRINCIPLES (Continued)
revenue is recognized. The standard also specifies that an entity should adjust the transaction price for the time value of the money in case the contract includes a significant financing component. The Group is currently evaluating the impact that the application of the new standard will have on its consolidated financial statements. The new standard was not endorsed by the European Union at the time these condensed consolidated financial statements were authorized for issuance.
Amendments to IAS 16 and 38Clarification of Acceptable Methods of Depreciation and Amortization. The Amendments clarify the use of the "revenue based methods" to calculate the depreciation of a building. The Amendments are applicable starting January 1, 2016 and are not yet endorsed by the European Union. The Group is currently evaluating the impact that the application of the new standard will have on its consolidated financial statements.
Amendments to IFRS 11: Accounting for Acquisitions of Interests in Joint Operation. The Amendments advise on how to account for acquisitions of interests in joint operations. The Amendments are applicable starting January 1, 2016 and are not yet endorsed by the European Union. The Group is currently evaluating the impact that the application of the new standard will have on its consolidated financial statements.
4. BUSINESS COMBINATIONS
On January 31, 2014, the Company completed the acquisition of glasses.com. The consideration for the acquisition was USD 40 million (approximately Euro 29.5 million). The difference between the consideration paid and the net assets acquired was provisionally recorded as goodwill and intangible assets. In accordance with IFRS 3Business combinations, the value of assets acquired and liabilities assumed will be definitively determined within 12 months after the acquisition date. Acquisition-related costs were approximately Euro 0.3 million and were expensed as incurred.
During the first nine months of 2014, the Group completed other minor acquisitions in the retail segment in Spain, Macao and Australia for total consideration of Euro 9.9 million. The difference between the consideration paid and the net assets acquired was provisionally recorded as goodwill, determined based on the future expected economic benefits.
At September 30, 2014, the valuation process has not yet been concluded, and the values set forth above together with goodwill have been determined on a provisional basis. In accordance with IFRS 3Business combinations, the value of the above assets acquired and liabilities assumed will be definitively determined within 12 months after the acquisition date.
37
Notes to the
CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
AS OF SEPTEMBER 30, 2014
(UNAUDITED)
4. BUSINESS COMBINATIONS (Continued)
The following table summarizes the consideration paid, the provisional fair value of the assets acquired and liabilities assumed at the acquisition date for glasses.com (in thousands of Euro):
Consideration |
29,523 | |||
| | | | |
Total consideration |
29,523 | |||
| | | | |
| | | | |
Recognized amount of identifiable assets and liabilities assumed |
||||
Accounts receivablenet |
50 | |||
Inventory |
3,096 | |||
Other current receivables |
286 | |||
Fixed assets |
5,230 | |||
Intangible assets |
9,917 | |||
Other current liabilities |
(1,279 | ) | ||
Total net identifiable assets |
17,304 | |||
Provisional Goodwill |
12,220 | |||
| | | | |
Total |
29,523 | |||
5. SEGMENT REPORTING
In accordance with IFRS 8Operating segments, the Group operates in two industry segments: (1) Manufacturing and Wholesale Distribution and (2) Retail Distribution.
The criteria applied to identify the reporting segments are consistent with the way the Group is managed. In particular, the disclosures are consistent with the information periodically analyzed by the Group's Chief Executive Officer, in his role as Chief Operating Decision Maker, to make decisions about resources to be allocated to the segments and assess their performance. Total assets for each reporting
38
Notes to the
CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
AS OF SEPTEMBER 30, 2014
(UNAUDITED)
5. SEGMENT REPORTING (Continued)
segment are no longer disclosed as they are not key indicators which are monitored in order to assess the Group's financial performance.
(Amounts in thousands of Euro) |
Manufacturing and Wholesale Distribution |
Retail Distribution |
Inter-segment transactions and corporate adjustments(c) |
Consolidated |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nine months ended September 30, 2014 (unaudited) |
|||||||||||||
Net sales(a) |
2,489,520 | 3,295,762 | | 5,785,282 | |||||||||
Income from operations(b) |
615,339 | 487,727 | (155,524 | ) | 947,541 | ||||||||
Interest income |
| | | 8,994 | |||||||||
Interest expense |
| | | (80,764 | ) | ||||||||
Other-net |
| | | (367 | ) | ||||||||
Income before provision for income taxes |
| | | 875,405 | |||||||||
Provision for income taxes |
| | | (316,373 | ) | ||||||||
Net income |
| | | 559,031 | |||||||||
Of which attributable to: |
|||||||||||||
Luxottica stockholders |
| | | 554,982 | |||||||||
Non-controlling interests |
| | | 4,049 | |||||||||
Capital expenditures |
105,998 | 164,063 | | 270,061 | |||||||||
Depreciation and amortization |
88,768 | 132,626 | 56,628 | 280,022 | |||||||||
Nine months ended September 30, 2013 (unaudited) |
|||||||||||||
Net sales(a) |
2,347,119 | 3,319,601 | | 5,666,720 | |||||||||
Income from operations(b) |
554,957 | 476,849 | (140,210 | ) | 891,596 | ||||||||
Interest income |
| | | 6,652 | |||||||||
Interest expense |
| | | (76,872 | ) | ||||||||
Other-net |
| | | (4,911 | ) | ||||||||
Income before provision for income taxes |
| | | 816,466 | |||||||||
Provision for income taxes |
| | | (293,919 | ) | ||||||||
Net income |
| | | 522,547 | |||||||||
Of which attributable to: |
|||||||||||||
Luxottica Stockholders |
| | | 518,755 | |||||||||
Non-controlling Interests |
| | | 3,792 | |||||||||
Capital expenditures |
93,630 | 141,627 | | 235,257 | |||||||||
Depreciation and amortization |
80,233 | 129,811 | 64,275 | 274,319 | |||||||||
39
Notes to the
CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
AS OF SEPTEMBER 30, 2014
(UNAUDITED)
NOTES TO THE CONSOLIDATED STATEMENT OF FINANCIAL POSITION
CURRENT ASSETS
6. CASH AND CASH EQUIVALENTS
(Amounts in thousands of Euro) |
As of September 30, 2014 (unaudited) |
As of December 31, 2013 (audited) |
|||||
---|---|---|---|---|---|---|---|
Cash at bank |
1,292,250 | 607,499 | |||||
Checks |
3,154 | 7,821 | |||||
Cash and cash equivalents on hand |
2,645 | 2,676 | |||||
| | | | | | | |
Total |
1,298,049 | 617,995 | |||||
| | | | | | | |
| | | | | | | |
The increase is mainly due to the issuance of a new bond for Euro 500 million in the first half of 2014. See note 21 and the consolidated cash flow statement for further details.
7. ACCOUNTS RECEIVABLE
(Amounts in thousands of Euro) |
As of September 30, 2014 (unaudited) |
As of December 31, 2013 (audited) |
|||||
---|---|---|---|---|---|---|---|
Accounts receivable |
834,136 | 715,527 | |||||
Allowance for doubtful accounts |
(42,138 | ) | (35,231 | ) | |||
| | | | | | | |
Total |
791,998 | 680,296 | |||||
| | | | | | | |
| | | | | | | |
The above are exclusively trade receivables and are recognized net of allowances to adjust their carrying amount to estimated realizable value. They are all due within 12 months.
8. INVENTORIES
(Amounts in thousands of Euro) |
As of September 30, 2014 (unaudited) |
As of December 31, 2013 (audited) |
|||||
---|---|---|---|---|---|---|---|
Raw materials |
181,943 | 163,809 | |||||
Work in process |
38,938 | 36,462 | |||||
Finished goods |
622,833 | 612,814 | |||||
Less: inventory obsolescence reserves |
(135,462 | ) | (114,135 | ) | |||
| | | | | | | |
Total |
708,252 | 698,950 | |||||
| | | | | | | |
| | | | | | | |
40
Notes to the
CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
AS OF SEPTEMBER 30, 2014
(UNAUDITED)
9. OTHER ASSETS
(Amounts in thousands of Euro) |
As of September 30, 2014 (unaudited) |
As of December 31, 2013 (audited) |
|||||
---|---|---|---|---|---|---|---|
Sales taxes receivable |
39,356 | 47,105 | |||||
Short-term borrowings |
695 | 770 | |||||
Accrued income |
2,154 | 1,418 | |||||
Other financial assets |
35,438 | 41,293 | |||||
| | | | | | | |
Total financial assets |
77,643 | 90,586 | |||||
| | | | | | | |
Income tax receivable |
28,353 | 46,554 | |||||
Advances to suppliers |
28,696 | 19,546 | |||||
Prepaid expenses |
63,914 | 51,469 | |||||
Other assets |
30,930 | 30,606 | |||||
| | | | | | | |
Total other assets |
151,892 | 148,175 | |||||
| | | | | | | |
Total other current assets |
229,535 | 238,761 | |||||
| | | | | | | |
| | | | | | | |
Other financial assets included amounts (i) recorded in the North American Retail Division totaling Euro 8.7 million as of September 30, 2014 (Euro 12.1 million as of December 31, 2013) and (ii) derivative financial assets of Euro 2.3 million as of September 30, 2014 (Euro 6.0 million as of December 31, 2013). The decrease in sales tax receivable is mainly due to certain Italian entities of the Group.
The decrease in income tax receivable is mainly due to certain U.S. subsidiaries of the Group utilizing receivables generated in 2013 to offset payments due in 2014.
Prepaid expenses mainly relate to the payments of monthly rental expenses incurred by the Group's North America and Asia-Pacific retail divisions.
Other assets include the short-term portion of advance payments made to certain designers for future contracted minimum royalties of Euro 30.9 million as of September 30, 2014 (Euro 30.6 million as of December 31, 2013).
The net book value of financial assets is approximately equal to their fair value and this value also corresponds to the maximum exposure of the credit risk. The Group has no guarantees or other instruments to manage credit risk.
41
Notes to the
CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
AS OF SEPTEMBER 30, 2014
(UNAUDITED)
NON-CURRENT ASSETS
10. PROPERTY, PLANT AND EQUIPMENT
Changes in items of property, plant and equipment during the first nine months of 2013 and 2014 were as follows:
(Amounts in thousands of Euro) |
Land and buildings, including leasehold improvements |
Machinery and equipment |
Aircraft |
Other equipment |
Total |
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Balance as of January 1, 2013 |
||||||||||||||||
Historical cost |
913,679 | 1,074,258 | 38,087 | 615,957 | 2,641,981 | |||||||||||
Accumulated depreciation |
(438,046 | ) | (668,561 | ) | (10,337 | ) | (332,644 | ) | (1,449,588 | ) | ||||||
| | | | | | | | | | | | | | | | |
Balance as of January 1, 2013 |
475,633 | 405,697 | 27,750 | 283,313 | 1,192,394 | |||||||||||
| | | | | | | | | | | | | | | | |
Increases |
33,438 | 66,432 | | 71,915 | 171,786 | |||||||||||
Decreases |
(3,147 | ) | | | (2,797 | ) | (5,944 | ) | ||||||||
Business combinations |
2,015 | 778 | | 908 | 3,701 | |||||||||||
Translation differences and other |
(1,338 | ) | 17,511 | | (52,512 | ) | (36,339 | ) | ||||||||
Depreciation expense |
(45,136 | ) | (70,264 | ) | (1,163 | ) | (42,909 | ) | (159,473 | ) | ||||||
| | | | | | | | | | | | | | | | |
Balance as of September 30, 2013 |
461,465 | 420,154 | 26,587 | 257,918 | 1,166,123 | |||||||||||
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
Historical cost |
916,326 | 1,114,603 | 38,087 | 594,735 | 2,663,750 | |||||||||||
Accumulated depreciation |
(454,861 | ) | (694,449 | ) | (11,500 | ) | (336,817 | ) | (1,497,626 | ) | ||||||
| | | | | | | | | | | | | | | | |
Balance as of September 30, 2013 |
461,465 | 420,154 | 26,587 | 257,918 | 1,166,123 | |||||||||||
(Amounts in thousands of Euro) |
Land and buildings, including leasehold improvements |
Machinery and equipment |
Aircraft |
Other equipment |
Total |
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Balance as of January 1, 2014 |
||||||||||||||||
Historical cost |
910,968 | 1,107,816 | 38,145 | 612,555 | 2,669,485 | |||||||||||
Accumulated depreciation |
(454,957 | ) | (681,918 | ) | (11,894 | ) | (337,480 | ) | (1,486,249 | ) | ||||||
| | | | | | | | | | | | | | | | |
Balance as of January 1, 2014 |
456,011 | 425,898 | 26,252 | 275,075 | 1,183,236 | |||||||||||
| | | | | | | | | | | | | | | | |
Increases |
39,309 | 58,345 | 7,522 | 72,101 | 177,277 | |||||||||||
Decreases |
(1,294 | ) | (2,636 | ) | (2,893 | ) | (3,229 | ) | (10,052 | ) | ||||||
Business combinations |
4 | 4,792 | | 724 | 5,520 | |||||||||||
Translation differences and other |
33,377 | 47,190 | 3,807 | (16,134 | ) | 68,240 | ||||||||||
Depreciation expense |
(44,205 | ) | (75,694 | ) | (1,268 | ) | (43,535 | ) | (164,702 | ) | ||||||
Balance as of September 30, 2014 |
483,202 | 457,896 | 33,420 | 285,003 | 1,259,520 | |||||||||||
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
Historical cost |
1,001,099 | 1,235,699 | 45,971 | 676,653 | 2,959,421 | |||||||||||
Accumulated depreciation |
(517,899 | ) | (777,803 | ) | (12,550 | ) | (391,649 | ) | (1,699,902 | ) | ||||||
| | | | | | | | | | | | | | | | |
Balance as of September 30, 2014 |
483,202 | 457,896 | 33,420 | 285,003 | 1,259,520 | |||||||||||
42
Notes to the
CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
AS OF SEPTEMBER 30, 2014
(UNAUDITED)
10. PROPERTY, PLANT AND EQUIPMENT (Continued)
The increase in property, plant and equipment from business combinations is mainly due to the acquisition of glasses.com. For further details about the effects of the acquisition of glasses.com please refer to Note 4"Business combinations."
Of the total depreciation expense of Euro 164.7 million for the first nine months of 2014 (Euro 159.5 million in the same period of 2013), Euro 61.2 million (Euro 53.9 million in the same period of 2013) is included in cost of sales, Euro 80.5 million (Euro 83.2 million in the same period of 2013) in selling expenses, Euro 5.4 million (Euro 3.6 million in the same period of 2013) in advertising expenses and Euro 17.6 million (Euro 18.8 million in the same period of 2013) in general and administrative expenses.
Capital expenditures in the first nine months of 2014 and 2013 mainly relate to routine technology upgrades to the manufacturing infrastructure, opening of new stores and the remodeling of older stores with leases that were extended during their respective periods.
Other equipment includes Euro 64.5 million for assets under construction at September 30, 2014 (Euro 70.9 million at December 31, 2013).
Leasehold improvements totaled Euro 159.8 million and Euro 149.5 million at September 30, 2014 and December 31, 2013, respectively.
11. GOODWILL AND INTANGIBLE ASSETS
Changes in intangible assets in the first nine months of 2013 and 2014 were as follows:
(Amounts in thousands of Euro) |
Goodwill |
Trade names and Trademarks |
Customer relations, contracts and lists |
Franchise agreements |
Other intangible assets |
Total |
|||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Balance as of January 1, 2013 |
|||||||||||||||||||
Historical cost |
3,148,770 | 1,563,447 | 247,730 | 21,752 | 547,966 | 5,528,665 | |||||||||||||
Accumulated amortization |
| (713,608 | ) | (83,553 | ) | (8,433 | ) | (228,614 | ) | (1,034,208 | ) | ||||||||
| | | | | | | | | | | | | | | | | | | |
Balance as of January 1, 2013 |
3,148,770 | 849,839 | 164,177 | 13,319 | 318,352 | 4,494,457 | |||||||||||||
| | | | | | | | | | | | | | | | | | | |
Increases |
| 23 | | | 66,647 | 66,670 | |||||||||||||
Decreases |
| | | | (390 | ) | (390 | ) | |||||||||||
Intangible assets from business acquisitions |
62,145 | 23,808 | | | 4,261 | 90,214 | |||||||||||||
Translation differences and other |
(103,347 | ) | (26,926 | ) | (6,269 | ) | (286 | ) | 5,258 | (131,570 | ) | ||||||||
Amortization expense |
| (52,100 | ) | (11,146 | ) | (817 | ) | (50,782 | ) | (114,846 | ) | ||||||||
| | | | | | | | | | | | | | | | | | | |
Balance as of September 30, 2013 |
3,107,568 | 794,645 | 146,762 | 12,215 | 343,346 | 4,404,535 | |||||||||||||
| | | | | | | | | | | | | | | | | | | |
Historical cost |
3,107,568 | 1,521,525 | 238,626 | 21,251 | 612,609 | 5,501,579 | |||||||||||||
Accumulated amortization |
| (726,880 | ) | (91,865 | ) | (9,036 | ) | (269,263 | ) | (1,097,044 | ) | ||||||||
| | | | | | | | | | | | | | | | | | | |
Balance as of September 30, 2013 |
3,107,568 | 794,645 | 146,762 | 12,215 | 343,346 | 4,404,535 | |||||||||||||
43
Notes to the
CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
AS OF SEPTEMBER 30, 2014
(UNAUDITED)
11. GOODWILL AND INTANGIBLE ASSETS (Continued)
(Amounts in thousands of Euro) |
Goodwill |
Trade names and Trademarks |
Customer relations, contracts and lists |
Franchise agreements |
Other intangible assets |
Total |
|||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Balance as of January 1, 2014 |
|||||||||||||||||||
Historical cost |
3,045,216 | 1,490,809 | 231,621 | 20,811 | 624,468 | 5,412,925 | |||||||||||||
Accumulated amortization |
| (729,915 | ) | (93,148 | ) | (9,109 | ) | (274,400 | ) | (1,106,572 | ) | ||||||||
| | | | | | | | | | | | | | | | | | | |
Balance as of January 1, 2014 |
3,045,216 | 760,894 | 138,473 | 11,702 | 350,068 | 4,306,353 | |||||||||||||
| | | | | | | | | | | | | | | | | | | |
Increases |
| 36 | | | 94,529 | 94,565 | |||||||||||||
Decreases |
| | | | (221 | ) | (221 | ) | |||||||||||
Intangible assets from business acquisitions |
22,685 | 5,351 | | | 6,915 | 34,951 | |||||||||||||
Translation differences and other |
214,964 | 59,154 | 11,483 | 1,062 | 29,924 | 316,582 | |||||||||||||
Amortization expense |
| (48,019 | ) | (10,318 | ) | (794 | ) | (56,189 | ) | (115,321 | ) | ||||||||
| | | | | | | | | | | | | | | | | | | |
Balance as of September 30, 2014 |
3,282,865 | 777,416 | 139,638 | 11,970 | 425,026 | 4,636,916 | |||||||||||||
| | | | | | | | | | | | | | | | | | | |
Of which |
|||||||||||||||||||
Historical cost |
3,282,865 | 1,596,651 | 250,720 | 22,809 | 777,331 | 5,930,375 | |||||||||||||
Accumulated amortization |
| (819,235 | ) | (111,081 | ) | (10,839 | ) | (352,304 | ) | (1,293,459 | ) | ||||||||
| | | | | | | | | | | | | | | | | | | |
Balance as of September 30, 2014 |
3,282,865 | 777,416 | 139,638 | 11,970 | 425,026 | 4,636,916 | |||||||||||||
The increase in goodwill and other intangible assets from business acquisitions mainly relates to the acquisition of glasses.com in January 2014 for Euro 29.5 million (USD 40 million) and other minor acquisitions in the retail segment in Spain, Macao and Australia for Euro 9.9 million. For additional details on the acquisition please refer to Note 4"Business Combinations."
Of the total amortization expense of Euro 115.3 million for the first nine months of 2014 (Euro 114.8 million in the same period of 2013), Euro 2.0 million (Euro 3.5 million in the same period of 2013) is included in cost of sales, Euro 9.4 million (Euro 6.2 million in the same period of 2013) in selling expenses and Euro 103.9 million (Euro 105.1 million in the same period of 2013) in general and administrative expenses.
The increase in other intangible assets is mainly due to the continued implementation of a new IT platform.
12. INVESTMENTS
Investments amounted to Euro 58.7 million as of September 30, 2014 (Euro 58.1 million at December 31, 2013) and mainly included investments in (i) Eyebiz Laboratories Pty Limited of Euro 6.5 million (Euro 4.7 million at December 31, 2013) and (ii) Salmoiraghi & Viganò of Euro 41.0 million (Euro 42.6 as of December 31, 2013). On September 10, 2014 following an adjustment in the number of shares comprising Luxottica's investment in Salmoiraghi & Viganò, our percentage increased from 36.33 percent to 36.80 percent.
44
Notes to the
CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
AS OF SEPTEMBER 30, 2014
(UNAUDITED)
12. INVESTMENTS (Continued)
The following tables provide a roll-forward of Group's investment for the first nine months of 2014 and the assets, liabilities and net sales of Salmoiraghi & Viganò as of September 30, 2014:
As of January 1, 2013 |
42,567 | |||
Addition |
| |||
Share of profit from associate |
(1,531 | ) | ||
| | | | |
As of September 30, 2014 |
41,036 | |||
|
As of September 30, 2014 |
|||
---|---|---|---|---|
Total assets |
174,659 | |||
Total liabilities |
143,060 | |||
Net sales |
130,913 | |||
Share of profit |
(1,531 | ) | ||
| | | | |
Percentage held |
36.80 | % | ||
13. OTHER NON-CURRENT ASSETS
(Amounts in thousands of Euro) |
As of September 30 2014 (unaudited) |
As of December 31 2013 (audited) |
|||||
---|---|---|---|---|---|---|---|
Other financial assets |
67,245 | 57,390 | |||||
Other assets |
47,416 | 69,193 | |||||
| | | | | | | |
Other non-current assets |
114,661 | 126,583 | |||||
| | | | | | | |
Other non-current financial assets were primarily comprised of security deposits of Euro 32.8 million as of September 30, 2014 (Euro 28.7 million at December 31, 2013). The remaining portion of the balance is split among the Group's subsidiaries, none of them representing significant amounts on a standalone basis as of September 30, 2014 and December 31, 2013 respectively.
The carrying value of financial assets approximates their fair value and corresponds to the Group's maximum exposure to credit risk. The Group does not utilize guarantees or other credit support instruments for managing credit risk.
Other assets include advance payments made to certain licensees for future contractual minimum royalties totaling Euro 47.4 million (Euro 69.2 million as of December 31, 2013).
45
Notes to the
CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
AS OF SEPTEMBER 30, 2014
(UNAUDITED)
14. DEFERRED TAX ASSETS AND LIABILITIES
The balance of deferred tax assets and liabilities as of September 30, 2014 and December 31, 2013 is as follows:
(Amounts in thousands of Euro) |
As of September 30 2014 (unaudited) |
As of December 31 2013 (audited) |
|||||
---|---|---|---|---|---|---|---|
Deferred tax assets |
200,877 | 172,623 | |||||
Deferred tax liabilities |
259,156 | 268,078 | |||||
| | | | | | | |
Deferred tax liabilities (net) |
58,279 | 95,455 | |||||
| | | | | | | |
Deferred tax assets primarily relate to temporary differences between the tax values and carrying amounts of inventories, fixed and intangible assets, pension funds, tax losses and provisions for risks and other charges. Deferred tax liabilities primarily relate to temporary differences between the tax values and carrying amounts of property, plant and equipment and intangible assets. The decrease in deferred tax liabilities (net) is mainly due to an increase in pension plan liabilities as a result of a decrease in the discount rate applied in September 2014 as compared to the one used to calculate liabilities as of December 31, 2013.
15. SHORT-TERM BORROWINGS
Short-term borrowings at September 30, 2014 reflect bank overdrafts and short term borrowings with various banks. The interest rates on these credit lines are floating. The credit lines may be used, if necessary, to obtain letters of credit.
As of September 30, 2014 and December 31, 2013, the Company had unused short-term lines of credit of approximately Euro 719.6 million and Euro 742.6 million, respectively.
The Company and its wholly-owned Italian subsidiary Luxottica S.r.l. maintain unsecured lines of credit with primary banks for an aggregate maximum credit of Euro 264.5 million. These lines of credit are renewable annually, can be cancelled at short notice and have no commitment fees. At September 30, 2014, these credit lines were utilized in the amount of Euro 0.1 million.
Luxottica U.S. Holdings Corp. ("US Holdings") maintains unsecured lines of credit with two separate banks for an aggregate maximum credit of Euro 98.0 million (USD 130.0 million). These lines of credit are renewable annually, can be cancelled at short notice and have no commitment fees. At September 30, 2014, Euro 4.9 million was utilized under these credit lines. However, there was Euro 45.0 million in aggregate face amount of standby letters of credit outstanding related to guarantees on these lines of credit.
The blended average interest rate on these lines of credit is LIBOR plus a spread up to 20 basis points based on the different lines of credit.
The carrying value of short-term borrowings approximates their fair value.
46
Notes to the
CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
AS OF SEPTEMBER 30, 2014
(UNAUDITED)
16. CURRENT PORTION OF LONG-TERM DEBT
This item consists of the current portion of loans granted to the Group, as further described below in Note 21"Long-term Debt."
17. ACCOUNTS PAYABLE
Accounts payable were Euro 712.1 million and Euro 681.2 million as of September 30, 2014 and December 31, 2013, respectively. The balance is due in its entirety within 12 months.
The carrying value of accounts payable approximates their fair value.
18. INCOME TAXES PAYABLE
The balance of income taxes payable is detailed below:
(Amounts in thousands of Euro) |
As of September 30, 2014 (unaudited) |
As of December 31, 2013 (audited) |
|||||
---|---|---|---|---|---|---|---|
Current year income taxes payable fund |
184,196 | 44,072 | |||||
Income taxes advance payment |
(39,808 | ) | (34,595 | ) | |||
| | | | | | | |
Total |
144,761 | 9,477 | |||||
| | | | | | | |
| | | | | | | |
The expected effective tax rate (36.1%) for 2014 is consistent with the effective tax rate as of December 31, 2013.
The increase in income tax payable is due to the timing of the tax payments in the different jurisdictions in which the Group operates.
47
Notes to the
CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
AS OF SEPTEMBER 30, 2014
(UNAUDITED)
19. SHORT TERM PROVISIONS FOR RISKS AND OTHER CHARGES
The balance as of September 30, 2013 and 2014 is detailed below respectively:
(Amounts in thousands of Euro) |
Legal risk |
Self-insurance |
Tax provision |
Other risks |
Returns |
Total |
|||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Balance as of December 31, 2012 |
578 | 4,769 | 12,150 | 12,477 | 36,057 | 66,032 | |||||||||||||
Increases |
580 | 7,211 | 646 | 14,544 | 17,571 | 40,552 | |||||||||||||
Decreases |
(690 | ) | (6,311 | ) | (1,031 | ) | (4,581 | ) | (18,064 | ) | (30,677 | ) | |||||||
Foreign translation difference reclassifications and other movements |
283 | (141 | ) | 104 | 67 | (557 | ) | (243 | ) | ||||||||||
| | | | | | | | | | | | | | | | | | | |
Balance as of September 30, 2013 |
752 | 5,529 | 11,870 | 22,507 | 35,007 | 75,664 | |||||||||||||
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
(Amounts in thousands of Euro) |
Legal risk |
Self-insurance |
Tax provision |
Other risks |
Returns |
Total |
|||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Balance as of December 31, 2013 |
997 | 5,535 | 63,928 | 14,772 | 38,455 | 123,688 | |||||||||||||
Increases |
1,881 | 5,822 | 20 | 18,418 | 20,122 | 46,264 | |||||||||||||
Decreases |
(115 | ) | (5,500 | ) | (26 | ) | (9,764 | ) | (12,789 | ) | (28,195 | ) | |||||||
Foreign translation difference reclassifications and other movements |
110 | 395 | 225 | 3 | 2,744 | 3,478 | |||||||||||||
| | | | | | | | | | | | | | | | | | | |
Balance as of September 30, 2014 |
2,872 | 6,252 | 64,147 | 23,429 | 48,533 | 145,233 | |||||||||||||
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
The Company is self-insured for certain losses relating to workers' compensation, general liability, auto liability, and employee medical benefits for claims filed and for claims incurred but not reported. The Company's liability is estimated on an undiscounted basis using historical claims experience and industry averages.
Legal risk includes provisions for various litigated matters that have occurred in the ordinary course of business.
The tax provision mainly includes a total accrual of approximately Euro 40.0 million related to the tax audit of Luxottica S.r.l. for fiscal years subsequent to 2007.
48
Notes to the
CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
AS OF SEPTEMBER 30, 2014
(UNAUDITED)
20. OTHER LIABILITIES
(Amounts in thousands of Euro) |
As of September 30, 2014 (unaudited) |
As of December 31, 2013 (audited) |
|||||
---|---|---|---|---|---|---|---|
Premiums and discounts |
4,272 | 2,674 | |||||
Leasing rental |
18,348 | 16,535 | |||||
Insurance |
9,506 | 10,008 | |||||
Sales taxes payable |
33,865 | 37,838 | |||||
Salaries payable |
271,964 | 228,856 | |||||
Due to social security authorities |
31,125 | 33,640 | |||||
Sales commissions |
7,749 | 9,008 | |||||
Royalties payable |
1,950 | 3,742 | |||||
Derivative financial liabilities |
9,704 | 1,729 | |||||
Other liabilities |
124,017 | 130,852 | |||||
| | | | | | | |
Total financial liabilities |
512,501 | 474,882 | |||||
| | | | | | | |
Deferred income |
7,546 | 9,492 | |||||
Advances from customers |
26,755 | 33,396 | |||||
Other liabilities |
5,785 | 5,280 | |||||
| | | | | | | |
Total liabilities |
40,086 | 48,168 | |||||
| | | | | | | |
Total other current liabilities |
552,587 | 523,050 | |||||
| | | | | | | |
| | | | | | | |
21. LONG-TERM DEBT
Long-term debt was Euro 2,293.9 million and Euro 2,053.4 million as of September 30, 2014 and 2013, respectively.
The roll-forward of long term debt as of September 30, 2013 and 2014 is as follows:
(Amounts in thousands of Euro) |
Luxottica Group S.p.A. credit agreement with various financial institutions |
Senior unsecured guaranteed notes |
Credit agreement with various financial institutions |
Credit agreement with various financial institutions for Oakley acquisition |
Other loans with banks and other third parties |
Total |
|||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Balance as of January 1, 2013 |
367,743 | 1,723,225 | 45,664 | 174,922 | 50,624 | 2,362,178 | |||||||||||||
| | | | | | | | | | | | | | | | | | | |
Proceeds from new and existing loans |
| | | | 4,319 | 4,319 | |||||||||||||
Repayments |
(70,000 | ) | (15,189 | ) | (45,880 | ) | (175,374 | ) | (22,093 | ) | (328,537 | ) | |||||||
Loans assumed in business combinations |
| | | | 16,062 | 16,062 | |||||||||||||
Amortization of fees and interests |
322 | 8,531 | 34 | 96 | 4,420 | 13,403 | |||||||||||||
Foreign translation difference |
| (13,731 | ) | 183 | 355 | (869 | ) | (14,062 | ) | ||||||||||
Balance as of September 30, 2013 |
298,066 | 1,702,835 | | | 52,462 | 2,053,363 | |||||||||||||
49
Notes to the
CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
AS OF SEPTEMBER 30, 2014
(UNAUDITED)
21. LONG-TERM DEBT (Continued)
(Amounts in thousands of Euro) |
Luxottica Group S.p.A. credit agreement with various financial institutions |
Senior unsecured guaranteed notes |
Other loans with banks and other third parties |
Total |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Balance as of January 1, 2014 |
298,478 | 1,683,970 | 52,061 | 2,034,510 | |||||||||
| | | | | | | | | | | | | |
Proceeds from new and existing loans |
| 494,655 | 5,325 | 499,980 | |||||||||
Repayments |
(300,000 | ) | | (18,346 | ) | (318,346 | ) | ||||||
Loans assumed in business combinations |
| | | | |||||||||
Amortization of fees and interests |
1,521 | 17,763 | | 19,284 | |||||||||
Foreign translation difference |
| 54,958 | 3,517 | 58,475 | |||||||||
Balance as of September 30, 2014 |
| 2,251,345 | 42,556 | 2,293,901 | |||||||||
The Group uses debt financing to raise financial resources for long-term business operations and to finance acquisitions. The Group continues to seek debt refinancing at favorable market rates and actively monitors the debt capital markets in order to take appropriate action to issue debt, when appropriate. Our debt agreements contain certain covenants, including covenants that limit our ability to incur additional indebtedness (for more details see note 3(f)Default risk: negative pledges and financial covenants to the 2013 Consolidated Financial Statements). As of September 30, 2014, we were in compliance with these financial covenants.
The table below summarizes the Group's long-term debt.
Type |
Series |
Issuer/Borrower |
Issue Date |
CCY |
Amount |
Outstanding amount at the reporting date |
Coupon / Pricing |
Interest rate as of September 30, 2014 |
Maturity |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Private Placement |
B | Luxottica US Holdings | July 1, 2008 | USD | 127,000,000 | 127,000,000 | 6.420% | 6.420 | % | July 1, 2015 | |||||||||||
Bond (Listed on Luxembourg Stock Exchange) |
Luxottica Group S.p.A. | November 10, 2010 | EUR | 500,000,000 | 500,000,000 | 4.000% | 4.000 | % | November 10, 2015 | ||||||||||||
Private Placement |
D | Luxottica US Holdings | January 29, 2010 | USD | 50,000,000 | 50,000,000 | 5.190% | 5.190 | % | January 29, 2017 | |||||||||||
Revolving Credit Facility 2012 |
Luxottica Group S.p.A. | April 17, 2012 | EUR | 500,000,000 | | Euribor + 1.30%/2.25% | | April 10, 2019 | |||||||||||||
Private Placement |
G | Luxottica Group S.p.A. | September 30, 2010 | EUR | 50,000,000 | 50,000,000 | 3.750% | 3.750 | % | September 15, 2017 | |||||||||||
Private Placement |
C | Luxottica US Holdings | July 1, 2008 | USD | 128,000,000 | 128,000,000 | 6.770% | 6.770 | % | July 1, 2018 | |||||||||||
Private Placement |
F | Luxottica US Holdings | January 29, 2010 | USD | 75,000,000 | 75,000,000 | 5.390% | 5.390 | % | January 29, 2019 | |||||||||||
Bond (Listed on Luxembourg Stock Exchange) |
Luxottica Group S.p.A. | March 19, 2012 | EUR | 500,000,000 | 500,000,000 | 3.625% | 3.625 | % | March 19, 2019 | ||||||||||||
Private Placement |
E | Luxottica US Holdings | January 29, 2010 | USD | 50,000,000 | 50,000,000 | 5.750% | 5.750 | % | January 29, 2020 | |||||||||||
Private Placement |
H | Luxottica Group S.p.A. | September 30, 2010 | USD | 50,000,000 | 50,000,000 | 4.250% | 4.250 | % | September 15, 2020 | |||||||||||
Private Placement |
I | Luxottica US Holdings | December 15, 2011 | USD | 350,000,000 | 350,000,000 | 4.350% | 4.350 | % | December 15, 2021 | |||||||||||
Bond (Listed on Luxembourg Stock Exchange) |
Luxottica Group S.p.A. | February 10, 2014 | EUR | 500,000,000 | 500,000,000 | 2.625% | 2.625 | % | February 10, 2024 | ||||||||||||
The floating rate measures under "Coupon/Pricing" are based on the corresponding Euribor (Libor for US dollar loans) plus a margin in the range, indicated in the table, based on the "Net Debt/EBITDA" ratio, as defined in the applicable debt agreement.
50
Notes to the
CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
AS OF SEPTEMBER 30, 2014
(UNAUDITED)
21. LONG-TERM DEBT (Continued)
On March 19, 2012, the Group completed an offering in Europe to institutional investors of Euro 500 million of senior unsecured guaranteed notes due March 19, 2019. The Notes are listed on the Luxembourg Stock Exchange under ISIN XS0758640279. Interest on the Notes accrues at 3.625% per annum. The Notes are guaranteed on a senior unsecured basis by U.S. Holdings and Luxottica S.r.l. On January 20, 2014, the Notes were assigned an A- credit rating by Standard & Poor's.
On April 17, 2012, the Group and U.S. Holdings entered into a multicurrency (Euro/USD) revolving credit facility with a group of banks providing for loans in the aggregate principal amount of Euro 500 million (or the equivalent in U.S. dollars) guaranteed by Luxottica Group, Luxottica S.r.l. and U.S. Holdings. The agent for this credit facility is Unicredit AG Milan Branch and the other lending banks are Bank of America Securities Limited, Citigroup Global Markets Limited, Crédit Agricole Corporate and Investment BankMilan Branch, Banco Santander S.A., The Royal Bank of Scotland PLC and Unicredit S.p.A. The facility matures on April 10, 2019 and was not drawn as of September 30, 2014.
On May 10, 2013 the Group Board of Directors authorized a Euro 2 billion "Euro Medium Term Note Programme" pursuant to which Luxottica Group S.p.A. may from time to time offer notes to investors in certain jurisdictions (excluding the United States, Canada, Japan and Australia). The notes issued under this program are listed on the Luxembourg Stock Exchange.
On February 10, 2014, the Group completed an offering in Europe to institutional investors of Euro 500 million of senior unsecured guaranteed notes due February 10, 2024. The Notes are listed on the Luxembourg Stock Exchange under ISIN XS1030851791. Interest on the Notes accrues at 2.625% per annum. The Notes were assigned an A- credit rating.
On August 29, 2014, the Group repaid the Mediobanca Term Loan in the amount of Euro 300 million. This payment was made three months prior to the expiration of the contract (scheduled for November 30, 2014).
The fair value of long-term debt as of September 30, 2014 was equal to Euro 2,460.2 million of which Euro 106.8 million was short-term debt (Euro 2,144.9 as of December 31, 2013). The fair value of the debt equals the present value of future cash flows, calculated by utilizing the market rate currently available for similar debt, and adjusted in order to take into account the Group's current credit rating. The fair value of long-term debt excludes lease liabilities (Euro 21.3 million).
On September 30, 2014 the Group had unused uncommitted lines (revolving) of Euro 500 million.
51
Notes to the
CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
AS OF SEPTEMBER 30, 2014
(UNAUDITED)
21. LONG-TERM DEBT (Continued)
Long-term debt, including capital lease obligations, as of September 30, 2014, matures as follows:
(Amounts in thousands of Euro) |
|
|||
---|---|---|---|---|
2014 |
| |||
2015 |
625,113 | |||
2016 |
| |||
2017 |
108,108 | |||
2018 and subsequent years |
1,529,218 | |||
Effect deriving from the adoption of the amortized cost method |
31,464 | |||
| | | | |
Total |
2,293,901 | |||
The net financial position and disclosure required by the Consob communication n. DEM/6064293 dated July 28, 2006 and by the CESR recommendation dated February 10, 2005 "Recommendation for the consistent application of the European Commission regulation on Prospectus" is as follows:
|
(Amounts in thousands of Euro) |
Notes |
September 30, 2014 unaudited |
December 31, 2013 audited |
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
A |
Cash and cash equivalents |
6 | 1,298,049 | 617,995 | ||||||||
B |
Other availabilities |
| | |||||||||
C |
Hedging instruments on foreign exchange rates |
9 | 2,272 | 6,039 | ||||||||
D |
Availabilities (A) + (B) + (C) |
1,300,320 | 624,035 | |||||||||
E |
Current Investments |
|||||||||||
F |
Bank overdrafts |
15 | 122,811 | 44,921 | ||||||||
G |
Current portion of long-term debt |
16 | 103,794 | 318,100 | ||||||||
H |
Hedging instruments on foreign exchange rates |
20 | 9,704 | 1,471 | ||||||||
I |
Hedging instruments on interest rates |
20 | | | ||||||||
J |
Current Liabilities (F) + (G) + (H) + (I) |
236,309 | 364,492 | |||||||||
K |
Net Liquidity (J) - (E) - (D) |
(1,064,011 | ) | (259,543 | ) | |||||||
L |
Long-term debt |
21 | 39,692 | 32,440 | ||||||||
M |
Notes payables |
21 | 2,150,417 | 1,683,970 | ||||||||
N |
Hedging instruments on interest rates |
21 | | | ||||||||
O |
Total Non-Current Liabilities (L) + (M) + (N) |
2,190,107 | 1,716,410 | |||||||||
P |
Net Financial Position (K) + (O) |
1,126,096 | 1,456,867 | |||||||||
52
Notes to the
CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
AS OF SEPTEMBER 30, 2014
(UNAUDITED)
21. LONG-TERM DEBT (Continued)
A reconciliation between the net financial position above and the net financial position presented in the Management Report is as follows:
(Amounts in thousands of Euro) |
September 30, 2014 (unaudited) |
December 31, 2013 (audited) |
|||||
---|---|---|---|---|---|---|---|
Net Financial Position, as presented in the Notes |
1,126,096 | 1,456,867 | |||||
| | | | | | | |
Hedging instruments on foreign exchange rates |
2,272 | 6,039 | |||||
Hedging instruments on interest ratesST |
| | |||||
Hedging instruments on foreign exchange rates |
(9,704 | ) | (1,471 | ) | |||
Hedging instruments on interest ratesLT |
| | |||||
| | | | | | | |
Net Financial Position |
1,118,663 | 1,461,435 | |||||
Our net financial position with respect to related parties is not material.
In order to determine the fair value of financial instruments, the Group utilizes valuation techniques which are based on observable market prices (Mark to Market). These techniques therefore fall within Level 2 of the hierarchy of Fair Values identified by IFRS 13.
IFRS 13 refers to valuation hierarchy techniques which are based on three levels:
In order to select the appropriate valuation techniques to utilize, the Group complies with the following hierarchy:
The Group determined the fair value of the derivatives existing on September 30, 2014 through valuation techniques which are commonly used for instruments similar to those traded by the Group. The models applied to value the instruments are based on a calculation obtained from the Bloomberg information service. The input data used in these models are based on observable market prices (Euro and USD interest rate curves as well as official exchange rates on the date of valuation) obtained from Bloomberg.
53
Notes to the
CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
AS OF SEPTEMBER 30, 2014
(UNAUDITED)
21. LONG-TERM DEBT (Continued)
The following table summarizes the financial assets and liabilities of the Group valued at fair value (in thousands of Euro):
|
|
|
Fair Value Measurements at Reporting Date Using: |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Classification within the Consolidated Statement of Financial Position |
|
|||||||||||||
|
September 30, 2014 |
||||||||||||||
Description |
Level 1 |
Level 2 |
Level 3 |
||||||||||||
Foreign Exchange Contracts |
Other current assets | 2,272 | | 2,272 | | ||||||||||
Foreign Exchange Contracts and Interest Rate Derivatives |
Other current liabilities | 9,704 | | 9,704 | | ||||||||||
|
|
|
Fair Value Measurements at Reporting Date Using: |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Classification within the Consolidated Statement of Financial Position |
|
|||||||||||||
|
December 31, 2013 |
||||||||||||||
Description |
Level 1 |
Level 2 |
Level 3 |
||||||||||||
Foreign Exchange Contracts |
Other current assets | 6,039 | | 6,039 | | ||||||||||
Interest Rate Derivatives |
Other current liabilities | 1,471 | | 1,471 | | ||||||||||
As of September 30, 2014 and December 31, 2013, the Group did not have any Level 3 fair value measurements.
The Group maintains policies and procedures with the aim of valuing the fair value of assets and liabilities using the best and most relevant data available.
The Group portfolio of foreign exchange derivatives includes only forward foreign exchange contracts on the most traded currencies with maturities of less than one year. The fair value of the portfolio is valued using observable market inputs including yield curves and foreign exchange spot and forward prices.
22. EMPLOYEE BENEFITS
Employee benefits amounted to Euro 100.0 million as of September 30, 2014 (Euro 76.4 million at December 31, 2013). The balance mainly included liabilities related to post-employment benefits of our Italian employees of Euro 52.0 million (Euro 46.8 million as of December 31, 2013) and of our U.S. employees of Euro 48.1 million (Euro 29.6 million as of December 31, 2013). The increase is primarily due to a reduction in the discount rate used to calculate the net liabilities as of September 30, 2014.
54
Notes to the
CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
AS OF SEPTEMBER 30, 2014
(UNAUDITED)
23. LONG-TERM PROVISIONS FOR RISK AND OTHER CHARGES
The balance is detailed below (amounts in thousands of Euro):
(Amounts in thousands of Euro) |
Legal risk |
Self- insurance |
Tax provision |
Other risks |
Total |
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Balance as of December 31, 2012 |
8,741 | 24,049 | 60,907 | 25,915 | 119,612 | |||||||||||
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
Increases |
1,891 | 6,574 | 4,583 | (512 | ) | 12,536 | ||||||||||
Decreases |
(993 | ) | (6,637 | ) | (391 | ) | (1,279 | ) | (9,300 | ) | ||||||
Business combinations |
383 | | | 240 | 623 | |||||||||||
Translation difference reclassifications and other movements |
(124 | ) | (559 | ) | (824 | ) | (4,573 | ) | (6,080 | ) | ||||||
| | | | | | | | | | | | | | | | |
Balance as of September 30, 2013 |
9,899 | 23,427 | 64,275 | 19,791 | 117,391 | |||||||||||
(Amounts in thousands of Euro) |
Legal risk |
Self- insurance |
Tax provision |
Other risks |
Total |
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Balance as of December 31, 2013 |
9,944 | 23,481 | 45,556 | 18,563 | 97,544 | |||||||||||
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
Increases |
2,777 | 4,461 | 2,880 | 313 | 7,551 | |||||||||||
Decreases |
(3,128 | ) | (5,456 | ) | | (399 | ) | (6,104 | ) | |||||||
Translation difference reclassifications and other movements |
(189 | ) | 2,331 | 2,852 | 5,778 | 10,773 | ||||||||||
| | | | | | | | | | | | | | | | |
Balance as of September 30, 2014 |
9,405 | 24,816 | 51,288 | 24,255 | 109,764 | |||||||||||
Other risks include (i) accruals for risks related to sales agents of certain Italian companies of Euro 5.8 million (Euro 5.8 million as of December 31, 2013) and (ii) accruals for decommissioning costs of certain subsidiaries of the Group operating in the retail segment of Euro 3.4 million (Euro 3.1 million as of December 31, 2013).
For further details on the nature of the provision, see Note 19.
24. OTHER NON-CURRENT LIABILITIES
The balance of other non-current liabilities was Euro 82.1 million as of September 30, 2014 (Euro 74.2 million as of December 31, 2013).
Other non-current payables mainly include other long-term liabilities of the North American retail operations of Euro 40.9 million (Euro 40.3 million as of December 31, 2013).
55
Notes to the
CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
AS OF SEPTEMBER 30, 2014
(UNAUDITED)
25. LUXOTTICA GROUP STOCKHOLDERS' EQUITY
Capital stock
The share capital of Luxottica Group S.p.A. at September 30, 2014 amounted to Euro 28,844,101.08 and was comprised of 480,735,018 ordinary shares of stock with a par value of Euro 0.06 per share. At January 1, 2014, the capital stock amounted to Euro 28,653,640.38 and was comprised of 477,560,673 ordinary shares of stock with a par value of Euro 0.06 per share.
Following the exercise of 3,174,345 options to purchase ordinary shares of stock granted to employees under existing stock option plans, the capital stock increased by Euro 190,461 in the first nine months of 2014.
The 3,174,345 options exercised in the period included 27,000 from the 2005 grant, 109,435 from the 2008 grant, 195,000 from the 2009 ordinary grant (reassignment of the 2006 and 2007 ordinary grants), 1,400,000 from the extraordinary 2009 grant (reassignment of the 2006 performance grant), 87,500 from the ordinary 2009 grant, 343,160 from the ordinary 2010 grant and 1,012,250 from the 2011 ordinary grant.
Legal reserve
This reserve represents the portion of the Company's earnings that are not distributable as dividends, in accordance with article 2430 of the Italian Civil Code.
Additional paid-in capital
This reserve increases with the expensing of options or excess tax benefits from the exercise of options.
Retained earnings
These include subsidiaries' earnings that have not been distributed as dividends and the amount of consolidated subsidiaries' equity in excess of the corresponding carrying amounts of investments in the same subsidiaries. This item also includes amounts arising as a result of consolidation adjustments.
Translation of foreign operations
Translation differences are generated by the translation into Euro of financial statements prepared in currencies other than Euro.
Treasury reserve
Treasury reserve was equal to Euro 73.9 million as of September 30, 2014 (Euro 83.1 million as of December 31, 2013). The decrease of Euro 9.2 million was due to 509,500 grants to certain top executives of treasury shares as a result of the Group having achieved the financial targets identified by the Board of Directors under the 2011 PSP. As a result of these equity grants, the number of Group treasury shares was reduced to 3,647,725 as of September 30, 2014 from 4,157,225 as of December 31, 2013.
56
Notes to the
CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
AS OF SEPTEMBER 30, 2014
(UNAUDITED)
26. NON-CONTROLLING INTERESTS
Equity attributable to non-controlling interests amounted to Euro 8.1 million and Euro 7.1 million at September 30, 2014 and December 31, 2013, respectively.
27. NOTES TO THE CONSOLIDATED STATEMENT OF INCOME
Please refer to Section 3"Financial Results" in the Management Report on the Interim Financial Results as of September 30, 2014 (unaudited).
28. COMMITMENTS AND RISKS
The Group has commitments under contractual agreements in place. Such commitments related to the following:
Guarantees
57
Notes to the
CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
AS OF SEPTEMBER 30, 2014
(UNAUDITED)
28. COMMITMENTS AND RISKS (Continued)
Litigation
French Competition Authority Investigation
Our French subsidiary Luxottica France S.A.S., together with other major competitors in the French eyewear industry, has been the subject of an anti-competition investigation conducted by the French Competition Authority relating to pricing practices in such industry. The investigation is ongoing, and, to date, no formal action has yet been taken by the French Competition Authority. As a consequence, it is not possible to estimate or provide a range of potential liability that may be involved in this matter. The outcome of any such action, which the Group intends to vigorously defend, is inherently uncertain, and there can be no assurance that such action, if adversely determined, will not have a material adverse effect on our business, results of operations and financial condition.
Other proceedings
The Group is a defendant in various other lawsuits arising in the ordinary course of business. It is the opinion of the management of the Company that it has meritorious defenses against all such outstanding claims, which the Company will vigorously pursue, and that the outcome of such claims, individually or in the aggregate, will not have a material adverse effect on the Group's consolidated financial position or results of operations.
29. RELATED PARTY TRANSACTIONS
Licensing Agreements
The Group executed an exclusive worldwide license for the production and distribution of Brooks Brothers brand eyewear. The brand is held by Brooks Brothers Group, Inc. ("BBG"), which is owned and controlled by a director of the Company, Claudio Del Vecchio. The license expires on December 31, 2014 but is renewable until December 31, 2019. Royalties paid under this agreement to BBG amounted to Euro 0.6 million and Euro 0.7 million in the first nine months of 2014 and 2013, respectively.
Service Revenues
During the periods ended September 30, 2014 and 2013, respectively, U.S. Holdings performed consulting and advisory services relating to risk management and insurance for Brooks Brothers Group, Inc. Amounts received for the services provided during these periods were immaterial in each period. Management believes that the compensation received for these services was fair to the Company.
Incentive Stock Option Plan
On September 14, 2004, the Company announced that its primary stockholder, Leonardo Del Vecchio, had allocated 2.11% of the shares of the Companyequal to 9.6 million shares, owned by him through the company La Leonardo Finanziaria S.r.l. and currently owned through Delfin S.à r.l., a financial company owned by the Del Vecchio family, to a stock option plan for the senior management of the Company. The options became exercisable on June 30, 2006 following the meeting of certain economic objectives and, as such, the holders of these options became entitled to exercise such options beginning on that date until their termination in 2014. In the first nine months of 2014, the last 0.3 million rights were
58
Notes to the
CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
AS OF SEPTEMBER 30, 2014
(UNAUDITED)
29. RELATED PARTY TRANSACTIONS (Continued)
exercised as part of this plan. In the same period of 2013, 3.1 million rights were exercised. There were approximately 330 thousand options outstanding as of September 30, 2013.
A summary of related party transactions as of September 30, 2014 and September 30, 2013 is provided below:
|
Consolidated Statement of Income |
Consolidated Statement of Financial Position |
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
As of September 30, 2014 Related parties (Amounts in thousands of Euro) |
|||||||||||||
Revenues |
Costs |
Assets |
Liabilities |
||||||||||
Brooks Brothers Group, Inc |
264 | 583 | 26 | 318 | |||||||||
Eyebiz Laboratories Pty Limited |
3,975 | 37,890 | 9,802 | 11,155 | |||||||||
Salmoiraghi & Viganò |
12,535 | 7 | 54,711 | 1 | |||||||||
Others(28) |
1,951 | 12,596 | 2,848 | 12,268 | |||||||||
| | | | | | | | | | | | | |
Total |
18,725 | 51,077 | 67,387 | 23,742 | |||||||||
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
|
Consolidated Statement of Income |
Consolidated Statement of Financial Position |
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
As of September 30, 2013 Related parties (Amounts in thousands of Euro) |
|||||||||||||
Revenues |
Costs |
Assets |
Liabilities |
||||||||||
Brooks Brothers Group Inc |
372 | 635 | 150 | 78 | |||||||||
Eyebiz Laboratories Pty Limited |
1,246 | 33,281 | 5,621 | 5,216 | |||||||||
Salmoiraghi & Viganò |
10,699 | 9 | 54,644 | | |||||||||
Others |
436 | 617 | 643 | 483 | |||||||||
| | | | | | | | | | | | | |
Total |
12,753 | 34,541 | 61,059 | 5,777 | |||||||||
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
Total remuneration due to key managers in the first nine months of 2014 amounted to approximately Euro 39.9 million (Euro 22.6 million at September 30, 2013).
30. EARNINGS PER SHARE
Basic and diluted earnings per share were calculated as the ratio of net profit attributable to the stockholders of the Company for the periods ended September 30, 2014 and 2013, amounting to Euro 555.0 million and Euro 518.8 million, respectively, to the number of outstanding shares on such datesbasic and dilutive of the Company.
Basic earnings per share in the first nine months of 2014 amounted to Euro 1.17 compared to Euro 1.10 in the same period in 2013. Diluted earnings per share in the first nine months of 2014 amounted to Euro 1.16, compared to Euro 1.09 in the same period in 2013.
59
Notes to the
CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
AS OF SEPTEMBER 30, 2014
(UNAUDITED)
30. EARNINGS PER SHARE (Continued)
The table below provides a reconciliation of the weighted average number of shares used to calculate basic and diluted earnings per share:
|
As of September 30 | ||||||
---|---|---|---|---|---|---|---|
|
2014 |
2013 |
|||||
Weighted average shares outstandingbasic |
475,325,386 | 471,617,863 | |||||
Effect of dilutive stock options |
3,025,757 | 4,414,010 | |||||
Weighted average shares outstandingdilutive |
478,351,143 | 476,031,873 | |||||
Options not included in calculation of dilutive shares as the average value was greater than the average price during the respective period or performance measures related to the awards have not yet been met |
1,737,180 | 1,859,787 | |||||
31. ATYPICAL AND/OR UNUSUAL OPERATIONS
There were no atypical and/or unusual transactions, as defined by the Consob communication n. 60644293 dated July 28, 2006, that occurred in the first nine months of 2014 or 2013.
32. SEASONAL AND CYCLICAL EFFECTS ON OPERATIONS
We have historically experienced sales volume fluctuations by quarter due to seasonality associated with the sale of sunglasses, which represented 56.6 percent and 54.2 percent of our net sales in the first nine months of 2014 and 2013, respectively.
33. NON-RECURRING TRANSACTIONS
In the first nine months of 2014, the Group recorded a non-recurring expenditure amounting to Euro 15 million related to the termination agreement of the employment relationship and the administration relationship between Andrea Guerra and Luxottica Group SpA. The Group recorded a tax benefit related to these expenses of approximately Euro 4.1 million. In the first nine months of 2013, the Group incurred non-recurring expenses totaling Euro 9.0 million related to the restructuring of Alain Mikli International, a French luxury and contemporary eyewear company. The Group recorded a tax benefit related to these expenses of approximately Euro 3.1 million.
34. SHARE-BASED PAYMENTS
On April 29, 2014, a Performance Shares Plan for senior managers and employees of the Company identified by the Board of Directors of the Company (the "Board") was adopted (the "2013 PSP"). The beneficiaries of the 2013 PSP are granted the right to receive ordinary shares, without consideration, if certain financial targets set by the Board of Directors are achieved over a specified three-year period.
On the same date, the Board of Directors granted certain key employees 1,203,900 rights to receive ordinary shares ("units") pursuant to the 2013 PSP plan.
60
Notes to the
CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
AS OF SEPTEMBER 30, 2014
(UNAUDITED)
34. SHARE-BASED PAYMENTS (Continued)
The fair value of the units was estimated on the grant date using the binomial model and the following weighted average assumptions:
Share Price at grant date |
41.08 | |
Expected life |
3 years | |
Dividend Yield |
1.76% | |
The fair value of the units granted under the 2014 PSP was Euro 39.03 per unit.
35. SUBSEQUENT EVENTS
On October 13, 2014 the Board of Directors accepted the resignation of Enrico Cavatorta from the Board following disagreements on the current governance structure. Based on the termination agreement, Luxottica acknowledges that Enrico Cavatorta is to be paid a gross amount upon termination of his employment of Euro 4,000,000, in addition to the severance pay linked to the consensual termination of the employment relationship. Added to this incentive payment is the gross total amount of Euro 985,355 which shall be paid as part of the settlement and novation agreement in consideration of Enrico Cavatorta waiving, towards Luxottica Group S.p.A. and every other entity included in the Group, any claim or right in any case connected or related to the employment and administration relationships and their resolution. No sums were awarded in connection with Mr. Cavatorta's termination from the position of director and chief executive officer of Luxottica Group S.p.A. which was effective October 13, 2014. Roger Abravanel resigned from the Board of Directors for the same reason. Chairman Leonardo Del Vecchio assumed the CEO executive responsibilities ad interim while the co-CEO of Markets selection process is being finalized.
On October 22, 2014, Chairman Leonardo del Vecchio presented the profile of Adil Mehboob-Khan, a candidate for the role of co-CEO for Markets. The Board of Directors appointed the independent director Marco Mangiagalli as a member of the Human Resources Committee in place of Roger Abravanel, who recently resigned from the Board of Directors.
On October 29, 2014, Adil Mehboob-Khan was introduced to the Board, and was elected as a non-executive member of the Luxottica Board of Directors, upon his joining Luxottica in January 2015. During the same meeting, Massimo Vian was appointed as CEO for the Group, entrusting him on an interim basis with all executive responsibilities until Adil Mehboob-Khan joins Luxottica in early 2015. Mr. Vian was also appointed to the Group Board of Directors.
******************************************************
61
EXCHANGE RATES USED TO TRANSLATE FINANCIAL STATEMENTS PREPARED IN CURRENCIES OTHER THAN THE EURO
|
Average exchange rate as of September 30, 2014 |
Final exchange rate as of September 30, 2014 |
Average exchange rate as of September 30, 2013 |
Final exchange rate as of December 31, 2013 |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
(per €1) |
|||||||||||||
Argentine Peso |
10.8173 |
10.6506 |
6.9533 |
8.9891 |
|||||||||
Australian Dollar |
1.4760 | 1.4442 | 1.3468 | 1.5423 | |||||||||
Brazilian Real |
3.1028 | 3.0821 | 2.7910 | 3.2576 | |||||||||
Canadian Dollar |
1.4819 | 1.4058 | 1.3481 | 1.4671 | |||||||||
Chilean Peso |
760.1510 | 755.4610 | 643.0870 | 724.7690 | |||||||||
Chinese Renminbi |
8.3544 | 7.7262 | 8.1208 | 8.3491 | |||||||||
Colombian Peso |
2,631.8912 | 2,546.9300 | 2,441.9590 | 2,664.4199 | |||||||||
Croatian Kuna |
7.6242 | 7.6425 | 7.5621 | 7.6265 | |||||||||
Great Britain Pound |
0.8118 | 0.7773 | 0.8520 | 0.8337 | |||||||||
Hong Kong Dollar |
10.5067 | 9.7740 | 10.2147 | 10.6933 | |||||||||
Hungarian Forint |
308.7662 | 310.5700 | 296.7665 | 297.0400 | |||||||||
Indian Rupee |
82.2624 | 77.8564 | 75.6962 | 85.3660 | |||||||||
Israeli Shekel |
4.7322 | 4.6474 | 4.7919 | 4.7880 | |||||||||
Japanese Yen |
139.4859 | 138.1100 | 127.3121 | 144.7200 | |||||||||
Malaysian Ringgit |
4.3925 | 4.1314 | 4.1243 | 4.5221 | |||||||||
Mexican Peso |
17.7720 | 16.9977 | 16.6971 | 18.0731 | |||||||||
Namibian Dollar |
14.5356 | 14.2606 | 12.4944 | 14.5660 | |||||||||
New Zealand Dollar |
1.6004 | 1.6209 | 1.6119 | 1.6762 | |||||||||
Norwegian Krona |
8.2762 | 8.1190 | 7.6608 | 8.3630 | |||||||||
Peruvian Nuevo Sol |
3.8033 | 3.6434 | 3.5232 | 3.8586 | |||||||||
Polish Zloty |
4.1752 | 4.1776 | 4.2014 | 4.1543 | |||||||||
Russian Ruble |
48.0152 | 49.7653 | N/A | 45.3246 | |||||||||
Singapore Dollar |
1.7039 | 1.6063 | 1.6483 | 1.7414 | |||||||||
South African Rand |
14.5356 | 14.2606 | 12.4944 | 14.5660 | |||||||||
South Korean Won |
1,411.6170 | 1,330.3400 | 1,456.3916 | 1,450.9301 | |||||||||
Swedish Krona |
9.0405 | 9.1465 | 8.5802 | 8.8591 | |||||||||
Swiss Franc |
1.2180 | 1.2063 | 1.2315 | 1.2276 | |||||||||
Taiwan Dollar |
40.8326 | 38.3039 | 39.1552 | 41.1400 | |||||||||
Thai Baht |
43.9071 | 40.8000 | 40.0245 | 45.1780 | |||||||||
Turkish Lira |
2.9331 | 2.8779 | 2.4583 | 2.9605 | |||||||||
U.S. Dollar |
1.3549 | 1.2583 | 1.3167 | 1.3791 | |||||||||
United Arab Emirates Dirham |
4.9764 | 4.6216 | 4.8363 | 5.0654 | |||||||||
The officer responsible for preparing the Company's financial reports, Enrico Cavatorta, declares, pursuant to paragraph 2 of Article 154-bis of the Consolidated Law on Finance, that the accounting information contained in this report corresponds to the document results, books and accounting records.
Milan, October 29, 2014
Enrico
Cavatorta
(Manager responsible for financial reporting)
62
Luxottica Headquarters and Registered OfficePiazzale L. Cadorna 3, 20123 Milan, Italy - Tel. + 39.02.863341 - Fax + 39.02.86996550
Deutsche Bank Trust Company Americas (ADR Depositary Bank)60
Wall Street, New York, NY 10005 USA
Tel. + 1.212.250.9100 - Fax + 1.212.797.0327
LUXOTTICA SRL AGORDO, BELLUNO - ITALY LUXOTTICA BELGIUM NV BERCHEM - BELGIUM LUXOTTICA FASHION BRILLEN VERTRIEBS GMBH GRASBRUNN - GERMANY LUXOTTICA FRANCE SAS VALBONNE - FRANCE LUXOTTICA GOZLUK ENDUSTRI VE TICARET AS CIGLI - IZMIR - TURKEY LUXOTTICA HELLAS AE PALLINI - GREECE LUXOTTICA IBERICA SA BARCELONA - SPAIN LUXOTTICA NEDERLAND BV HEEMSTEDE - HOLLAND LUXOTTICA OPTICS LTD TEL AVIV - ISRAEL LUXOTTICA POLAND SP ZOO KRAKÓW - POLAND LUXOTTICA PORTUGAL-COMERCIO DE OPTICA SA LISBON - PORTUGAL LUXOTTICA (SWITZERLAND) AG ZURICH - SWITZERLAND LUXOTTICA CENTRAL EUROPE KFT BUDAPEST - HUNGARY LUXOTTICA SOUTH EASTERN EUROPE LTD NOVIGRAD - CROATIA LUXOTTICA RETAIL UK LIMITED ST. ALBANS - HERTFORDSHIRE (UK) OAKLEY ICON LIMITED DUBLIN - IRELAND ALAIN MIKLI INTERNATIONAL SAS PARIS - FRANCE |
LUXOTTICA TRADING AND FINANCE LIMITED DUBLIN - IRELAND LUXOTTICA NORDIC AB STOCKHOLM - SWEDEN LUXOTTICA U.K. LTD ST. ALBANS - HERTFORDSHIRE (UK) LUXOTTICA VERTRIEBSGESELLSCHAFT MBH WIEN - AUSTRIA LUXOTTICA U.S. HOLDINGS CORP. PORT WASHINGTON - NEW YORK (USA) LUXOTTICA USA LLC PORT WASHINGTON - NEW YORK (USA) LUXOTTICA CANADA INC. NEW BRUNSWICK (CANADA) LUXOTTICA NORTH AMERICA DISTRIBUTION LLC MASON - OHIO (USA) LUXOTTICA RETAIL NORTH AMERICA INC. MASON - OHIO (USA) SUNGLASS HUT TRADING, LLC MASON - OHIO (USA) EYEMED VISION CARE LLC MASON - OHIO (USA) LUXOTTICA RETAIL CANADA INC. NEW BRUNSWICK (CANADA) OAKLEY, INC. FOOTHILL RANCH - CALIFORNIA (USA) LUXOTTICA MEXICO SA DE CV MEXICO CITY - MEXICO OPTICAS GMO CHILE SA SANTIAGO - CHILE LUXOTTICA ARGENTINA SRL BUENOS AIRES - ARGENTINA |
LUXOTTICA BRASIL PRODUTOS OTICOS E ESPORTIVOS LTDA SÃO PAULO - BRAZIL LUXOTTICA AUSTRALIA PTY LTD MACQUARIE PARK - NEW SOUTH WALES (AUSTRALIA) OPSM GROUP PTY LIMITED MACQUARIE PARK - NEW SOUTH WALES (AUSTRALIA) LUXOTTICA MIDDLE EAST FZE DUBAI - DUBAI (UNITED ARAB EMIRATES) MIRARI JAPAN CO LTD TOKYO - JAPAN LUXOTTICA SOUTH AFRICA PTY LTD CAPE TOWN - OBSERVATORY (SOUTH AFRICA) RAYBAN SUN OPTICS INDIA LTD GURGAON - HARYANA (INDIA) SPV ZETA OPTICAL COMMERCIAL AND TRADING (SHANGHAI) CO., LTD SHANGHAI - CHINA LUXOTTICA TRISTAR (DONGGUAN) OPTICAL CO LTD DONG GUAN CITY, GUANGDONG - CHINA GUANGZHOU MING LONG OPTICAL TECHNOLOGY CO. LTD GUANGZHOU CITY - CHINA SPV ZETA OPTICAL TRADING (BEIJING) CO. LTD BEIJING - CHINA LUXOTTICA KOREA LTD SEOUL - KOREA LUXOTTICA SOUTH PACIFIC HOLDINGS PTY LIMITED MACQUARIE PARK - NEW SOUTH WALES (AUSTRALIA) LUXOTTICA (CHINA) INVESTMENT CO. LTD. SHANGHAI - CHINA LUXOTTICA WHOLESALE (THAILAND) LTD BANGKOK - THAILAND |
www.luxottica.com
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
LUXOTTICA GROUP S.P.A. | ||
Date: November 12, 2014 |
By: /s/ Michael A. Boxer MICHAEL A. BOXER GROUP GENERAL COUNSEL |